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ABSTRACT
Stinson, Jelynn A., Biomedical Sciences Ph.D. Program, Wright State University,
2012. Applications of Capillary Electrophoresis for Studying Serum Albumin
Enantioselection of D,L-Tryptophan Analogs.
The pharmacokinetic difference between drug enantiomers is the impetus for
developing analytical techniques to assess enantiomeric purity. Capillary
electrophoresis (CE) is an analytical technique that is used for characterizing drugprotein binding. The pitfall to using CE for drug-protein binding studies is protein
chiral selectors tend to adsorb onto capillary walls and cause changes in
electroosmotic flow that lead to decreased enantioselection and migration time
irreproducibility between consecutive injections. The experimental parameters for
minimizing the adverse effects of protein adsorption are not clear from the literature.
Rinsing protocols to improve enantioselection and migration time repeatability
were developed using the tryptophan-bovine serum albumin system as a model. The
enantioselection of bovine serum albumin (BSA) could be improved by: 1)
increasing separation voltage; 2) using sample buffer ionic strength at least 3 orders
of magnitude less than the separation buffer; 3) limiting the equilibration time with
separation buffer; and 4) allowing for protein diffusion. Rinsing the capillary with
sodium hydroxide, followed by water improved migration time repeatability RSD
from 24.7% to 1.8% (n = 4).

iii

Drug-protein binding is contingent upon the three dimensional structure of the
binding site, and the presence of other competing drug molecules. Drug-drug
displacement is difficult to predict and the effects of protein glycation on binding of
drugs is not well defined. To highlight the use of CE for addressing questions of
biochemical interest, CE was applied to characterize drug-drug displacement and the
effects of protein glycation on the enantioselection of drugs by BSA. The tryptophanbovine serum albumin, 5-fluoro-tryptophan-bovine serum albumin, and 5-hydroxytryptophan-bovine serum albumin systems were used as models.
A CE method for studying competitive binding was established using ibuprofen
as the displacer molecule. Accurate calculation of selectivity was found to depend on
the precomplexation of ibuprofen and BSA. A CE method for studying the effects
of protein glycation was developed using BSA containing different degrees of
glycation as chiral selectors. The enantioselection of tryptophan analogs by BSA was
altered by glycation as reported in other analytical methods. These studies can serve
as guidelines for optimizing serum albumin enantioselection and extending its use in
other biopharmaceutical applications.

iv

TABLE OF CONTENTS
Chapter 1: General Introduction
PAGE
1.1.
Background…………………………………………………………………………...1
1.2. Principles of Separation in Capillary Electrophoresis…………………………...9
1.2.1. Electrophoretic Mobility………………………………………………...10
1.2.2. Electroosmotic Flow……………………………………………………..11
1.2.3. Selectivity and Efficiency………………………………………………..14
1.2.4. Resolution………………………………………………………………..16
1.3. Capillary Electrophoresis for Enantioselective Analysis……………………….17
1.3.1. Common Chiral Selectors………………………………………………..20
1.3.1.1. Cyclodextrins……………………………………………………20
1.3.1.2. Micelles………………………………………………………….21
1.3.1.3. Macrocyclic Antibiotics…………………………………………26
1.3.1.4. Proteins………………………………………………………….29
1.3.1.4.1. Drug-serum albumin binding…………………………29
1.4. Factors that reduce tryptophan-serum albumin binding………………………..33
1.5. HYPOTHESIS...................................…………………………………………..37
Chapter 2: Materials and Methods
2.1. Chemicals……………………………………………………………………….38
2.2. Instrumentation…………………………………………………………………38
2.2.1. Capillary electrophoresis………………………………………………....38
2.2.2. Mass Spectrometer……………………………………………………….39
2.2.3. Proton Nuclear Magnetic Resonance…………………………………….39

v

TABLE OF CONTENTS (CONTINUED)
PAGE
2.3. Determine relevant parameters for improving enantioselection
and migration time reproducibility…………………………………………..….40
2.3.1. Ohm’s Law Plot………………………………………………………..…40
2.3.2. Applied voltage effects on peak shape………………………………..….42
2.3.3. Sodium hydroxide and water rinse effects on migration time………..…..44
2.3.4. Evaluating the selectivity as a function of BGE rinse time…………..…..45
2.3.5. Evaluating the selectivity as a function of WAIT time……………..……46
2.3.6. Evaluating the selectivity as a function of sample buffer ionic strength....47
2.4. Capillary electrophoresis applications for studying competitive binding…..…..48
2.5. Capillary electrophoresis applications for studying binding of glycated
serum proteins……………………………………………………………….....49
Chapter 3: Results and Discussion
3.1. Determine relevant parameters for improving enantioselection
and migration time reproducibility…………………………………………..…52
3.1.1. Ohm’s Law Plot……………………………………………………….....53
3.1.2. Applied voltage effects on peak shape………………………………..…57
3.1.3. Sodium hydroxide and water rinse effects on migration time...……..…..62
3.1.4. Evaluating the selectivity as a function of BGE rinse time.......................68
3.1.5. Evaluating the selectivity as a function of wait time.................................83
3.1.6. Evaluating the selectivity as a function of
sample buffer ionic strength……………………………………..……....95
3.2. Capillary electrophoresis applications for
studying competitive binding.............................................................................110
3.2.1. Determining sample concentration..........................................................110
3.2.2. Separation Selectivity..............................................................................120
3.2.3. Measuring the binding constant...............................................................128
3.2.4. Measuring the selectivity by
pre-formed displacer-protein binary complexes......................................131
3.3. Capillary electrophoresis applications for studying binding of glycated
serum proteins...................................................................................................132
3.3.1. Characterization of extent of glycation...................................................132
3.3.2. Chiral recognition of glycated BSA........................................................144

vi

TABLE OF CONTENTS (CONTINUED)
PAGE
Chapter 4: Conclusion and Future Studies
4.1. Summary.............................................................................................................165
List of References................................................................................................167
Appendix………………………………………………………………….………..177
List of Abbreviations………………………………………………….……....177

vii

LIST OF FIGURES
PAGE
Figure 1. Tryptophan and analogs : 5-fluoro-tryptophan; 5-hydroxy-tryptophan........4
Figure 2. Schematic of a Capillary Electrophoresis Instrument...................................8
Figure 3. Simplistic model of a double electric layer.................................................13
Figure 4. The three point interaction model...............................................................19
Figure 5. Structure of α- cyclodextrin........................................................................23
Figure 6. Schematic representation of the amphipathic molecule
sodium dodecyl sulfate (SDS)....................................................................25
Figure 7. Schematic of an ansa compound................................................................28
Figure 8. Albumin with the major drug binding sites labeled (PDB ID: 2BXG)......32
Figure 9. Formation of glycated albumin..................................................................36
Figure 10. Ohm’s law plots.........................................................................................55
Figure 11. Effect of 10 kV separation voltage on protein adsorption.........................59
Figure 12. Effect of 15 kV separation voltage on protein adsorption.........................61
Figure 13. The effect of sodium hydroxide/water rinse on repeatability....................65
Figure 14. D,L-tryptophan (0.54 mg/ml), 0 minute NaOH/water rinse
between injections.....................................................................................67
Figure 15. D,L-tryptophan (0.54 mg/ml), 8 minute BGE rinse..................................70
Figure 16. D,L-tryptophan (0.54 mg/ml), 16 minute BGE rinse................................72
Figure 17. D,L-tryptophan (0.54 mg/ml), 24 minute BGE rinse................................74
viii

LIST OF FIGURES (CONTINUED)
PAGE
Figure 18. D,L-tryptophan (0.54 mg/ml), 32 minute BGE rinse................................76
Figure 19. Selectivity versus BGE rinse time.............................................................78
Figure 20. First derivative of selectivity as a function of BGE rinse time.................80
Figure 21. Electroosmotic flow rate as a function of BGE rinse time........................82
Figure 22. D,L-tryptophan (0.54 mg/ml), 10 minute WAIT step...............................86
Figure 23. D,L-tryptophan (0.54 mg/ml), 40 minute WAIT step...............................88
Figure 24. D,L-tryptophan (0.54 mg/ml), 60 minute WAIT step...............................90
Figure 25. Selectivity versus WAIT time...................................................................92
Figure 26. First derivative of selectivity as a function of WAIT time.......................94
Figure 27. D,L-tryptophan (0.54 mg/ml), prepared in 5 mM sodium phosphate.......98
Figure 28. D,L-tryptophan (0.54 mg/ml), prepared in 8 mM sodium phosphate.....100
Figure 29. D,L-tryptophan (0.54 mg/ml), prepared in 15 mM sodium phosphate...102
Figure 30. D,L-tryptophan (0.54 mg/ml), prepared in 25 mM sodium phosphate...104
Figure 31. Selectivity versus sample buffer concentration.......................................106
Figure 32. First derivative of selectivity as a function
of sample buffer concentration................................................................108
Figure 33. Mobility shifts of D,L-tryptophan and 5-fluoro-D,L-tryptophan............112
Figure 34. D,L-tryptophan (0.22 mg/ml) run in 25 mM sodium phosphate..............115
Figure 35. 5-fluoro-D,L-tryptophan (0.22 mg/ml) run in sodium
phosphate...................................................................................................................117
Figure 36. Changes in baseline resolution due to nonlinear isotherm conditions.....119

ix

LIST OF FIGURES (CONTINUED)
PAGE
Figure 37. Separation selectivity of BSA (35 μM) for 5-fluoro-D,L-tryptophan
and D,L-tryptophan.................................................................................122
Figure 38. D,L-tryptophan (0.22 mg/ml) at a ibuprofen:BSA molar ratio of 1.6:1
(22 μM ibuprofen)....................................................................................125
Figure 39. 5-fluoro-D,L-tryptophan (0.22 mg/ml) at a ibuprofen:BSA molar ratio
of 1.6:1 (22 μM ibuprofen)......................................................................127
Figure 40. Binding constant estimates for 5-fluoro-D,L-tryptophan and
D,L-tryptophan to BSA (10- 35 μM).......................................................130
Figure 41. CE/UV peak profiles of unmodified and modified BSA in
25 mM sodium phosphate at pH 7.4.........................................................134
Figure 42. 1H NMR of BSA after 3 week incubation in 14 mM D-glucose.............143
Figure 43. D,L-tryptophan (0.22 mg/ml) binding by unmodified
and 1 week modified BSA........................................................................146
Figure 44. D,L-tryptophan (0.22 mg/ml) binding by 2 week modified
and 3 week modified BSA........................................................................148
Figure 45. 5-fluoro-D,L-tryptophan (0.22 mg/ml) binding by unmodified
and 1 week modified BSA........................................................................150
Figure 46. 5-fluoro-D,L-tryptophan (0.22 mg/ml) binding by 2 week modified
and 3 week modified BSA........................................................................152
Figure 47. 5-hydroxy-D,L-tryptophan (0.22 mg/ml) binding by unmodified
and 1 week modified BSA........................................................................154
Figure 48. 5-hydroxy-D,L-tryptophan (0.22 mg/ml) binding by 2 week modified
and 3 week modified BSA........................................................................156
Figure 49. Effect of glycation extent on BSA selectivity
of D,L-tryptophan....................................................................................158

x

LIST OF FIGURES (CONTINUED)
PAGE
Figure 50. Effect of glycation extent on BSA selectivity
of 5-fluoro-D,L-tryptophan.......................................................................160
Figure 51. Effect of glycation extent on BSA selectivity
of 5-hydroxy-D,L-tryptophan...................................................................162

xi

LIST OF TABLES
PAGE
TABLE I. Mass spectrometric analysis of glycated BSA
after 1 week incubation………………………………………………...137
TABLE II. Mass spectrometric analysis of glycated BSA
after 2 week incubation...........................................................................139
TABLE III. Mass spectrometric analysis of glycated BSA
after 3 week incubation..........................................................................141

xii

ACKNOWLEDGEMENTS
I wish to thank my faculty advisor, Dr. Roger Gilpin for his insights and guidance
throughout my time in the Biomedical Sciences Ph.D. program. His willingness in
allowing autonomy and supporting my ideas towards the completion of this project
was key in my development as a scientist. I wish to thank the members of my
dissertation committee for challenging me to make connections across scientific
disciplines. Your guidance has helped me to critically think about scientific
approaches. I wish to thank Dr. Nicholas Reo for the nuclear magnetic resonance
(NMR) analysis. He was instrumental in teaching me the basics of NMR and learning
how to accurately interpret data.
I would like to thank members of the Gilpin lab past and present for making my
stay in the laboratory enjoyable and conducive to scientific development. I have had
the opportunity to work with Joseph Solch and Garrett VanNess of the WSU
Chemistry Department. I appreciate their willingness in providing materials and
advice in addressing research problems. I will definitely miss our days filled with
lots of laughter.
Special thanks to my family for your love and support. I appreciate your
encouragement to pursue with all diligence the task set before me. I appreciate your
prayers and constantly reminding me that all things work together for good to those
who love The Lord. You are my motivation.
xiii

Chapter 1
General Introduction
1.1. Background
Although the majority of active pharmaceutical ingredients (API) are marketed as
racemates, typically only one isomer is pharmacologically active resulting in
decreased therapeutic efficacy of the formulated product. Likewise, dissimilar
properties of enantiomers can result in side effects that range from mild to deadly.
Because of these problems, there has been increasing demand for the production of
enantiomerically pure drugs by government agencies like the US Food and Drug
Administration (FDA). In order to assure the quality of these products there has been
increasing demand for reliable analytical methodology to assess enantiomeric purity
(Núñez, et al., 2009). It is this latter need that is the basis of the current work, which
is concerned with the characterization and optimization of serum albumin as a chiral
selector for carrying out enantiomeric separation by capillary electrophoresis. Unlike
other standard methods, capillary electrophoresis (CE) does not require the use of
pure enantiomers, which makes it easy to carry out experiments under various
conditions.
One of the major challenges to using a protein as a chiral selector is it has a
tendency to adsorb onto the inner walls of the bare-fused capillaries used in this
1

technique. In this case, drug molecules will interact not only with the protein in the
background electrolyte (BGE), but also with that adsorbed to the capillary wall.
Adsorbed protein has been reported to cause fluctuations of electroosmotic flow
(EOF). This leads to peak shape distortion like tailing and band broadening that
adversely affects resolution and efficiency (Ventura, et al., 2012). There is limited
information available in the literature pertaining to the experimental conditions that
are most relevant for improving chiral recognition of drugs by proteins. Capillary
rinsing strategies and adjustment of separation voltage have been reported to improve
separation (Sokoliess & Koller, 2005; Ribeiro, et al., 2011). The presence of protein
in the BGE presents a background absorbance that suppresses the sample signal if the
protein concentration is too high and detection is at a wavelength where the protein
absorbs strongly.
Tryptophan, one of the compounds used to carry out the CE chiral recognition
studies, is an amino acid that exists as both D- and L-stereoisomers. The D-and Lstructures, and two other tryptophan analogs used in the current study are shown in
Figure 1. Since tryptophan is a chemical precursor to the biosynthesis of serotonin, it
along with its analogs, are administered for treatment of diseases where there is
impaired synthesis of serotonin (Muck-Seler & Pivac, 2011). Tryptophan is used as
an additive in over the counter antidepressants, appetite suppressors, and in sleep aid
products (Doghramiji, P., 2006; Robinson et. al, 2012). Tryptophan and its analogs
also are administered in the treatment and diagnosis in more serious diseases such as
carcinoid tumor metastases, migraines, and attention-deficit/hyperactivity disorder
(Nikolaou, et.al., 2010; Johansson, et. al, 2011; Niederhofer, 2011).
2

Figure 1: Tryptophan and analogs : 5-fluoro-tryptophan; 5-hydroxy-tryptophan.
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Despite the advances made in stereoselective synthesis, the direct enantiomeric
synthesis of drugs may be expensive and not always achievable (Ye, 2011). For the
analogs investigated in this work, a single step synthesis has been reported for 5fluorotryptophan (Winn et al., 2008). There are a number of established techniques in
the pharmaceutical field used for stereoselective analysis (Christodoulou, 2010). Of
these, chiral separations performed using high pressure liquid chromatography
(HPLC) continues to be the preferred approach (Wong et al., 2008; McConnell et al.,
2007; Núñez, et al., 2009). Enantiomers are separated in HPLC either indirectly with
chiral derivatization reagents or directly with chiral stationary phases (CSPs). The
most important protein-based CSPs used in HPLC are based on human serum
albumin (HSA), α1-acid glycoprotein (AGP), crude ovumocoid (OVM) and
cellobiohydrolase I (Lammerhofer, 2010). The AGP CSPs have been used in the
enantioseparation of D,L-penicillamine, D,L-cysteine, and β2 agonist, formoterol
(Bhushan & Kumar, 2009; Akapo et al., 2009). Work has been carried out in our lab
to develop methods using immobilized human serum albumin, bovine serum albumin
(BSA), sheep albumin, and pig albumin in the enantioseparation of D,L-tryptophan
(Tittelbach & Gilpin, 1995). Bovine serum albumin-gold conjugates as stationary
phase have been described for use in chip-based enantioselective capillary
electrochromatography (Li et al., 2009). Recently, HPLC has been combined with
nuclear magnetic resonance (NMR) to screen the chromatographic enantiorecognition
process on CSPs as well as to determine the absolute configuration of enantiomers
(Uccello-Barretta et al., 2010; Cirilli et al., 2010; Thompson et al., 2009).

5

Other methods used for chiral separations include super-critical fluid
chromatography, and preparative and simulated moving bed chromatography
(Speybrouck et al., 2012; Zhang et al., 2012; Guiochon & Tarafder, 2011; Hsu et al.,
2011). Spectroscopic techniques such as NMR provide a clear view of the binding
mechanisms; however they have a high sample consumption rate (Oravcova et al.,
1996; Liu et al., 2008; Mathur et al., 2007). Chromatographic assays also require the
immobilization of the protein on a support, which alter the binding properties of the
protein (Ascoli et al., 2006; Hage et al., 2009). The cost efficiency and
environmental aspects of CE, such as the use of very small volumes of sample and
buffer solutions, along with short analysis time, and ease of automation make it
advantageous over other methods. Capillary electrophoresis has become a powerful
tool for the separation of chiral drugs and biomolecules as reviewed by a number of
publications on this topic (Altria & Elder, 2004; Natishan, 2005; Smith & Evans,
1994; Lu & Guonan, 2010; Liu et al., 2008). The first use of CE for chiral separation
was demonstrated in 1985 by Zare and co-workers, who resolved racemic mixtures of
dansylated amino acids (Gassmann et al., 1985).

6

Figure 2: Schematic of a Capillary Electrophoresis Instrument.
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Figure 2.
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1.2. Principles of separation in capillary electrophoresis
Capillary electrophoresis is a highly sensitive and selective method that separates
components based on solute velocity in an electric field. The direction of movement
is determined by the charge on the species, and the velocity is determined by the
electrosmotic flow (EOF), electric field strength, shape of the solute, and ionic
mobility. A general schematic of a capillary electrophoresis instrument is presented in
Figure 2. Present commercially available systems also have a thermostatting system
for temperature control.
Capillary electrophoretic separations are performed by first filling the capillary
with an appropriate background electrolyte (BGE). A sample plug is then drawn into
the capillary inlet by hydrodynamic or electrokinetic means. Both the cathode and
the anode are submerged in vials containing the BGE, and a voltage is applied to the
system. Solutes in the sample plug migrate along the capillary separating into zones
according to their electrophoretic mobilites that are determined by their mass to
charge ratio differences.

9

1.2.1. Electrophoretic Mobility

When a separation voltage is applied, an electric field E (V/L) (where V is the
voltage and L is the length of the capillary), develops along the length of the
capillary. Under the influence of this electric field, ionic species with charge q
experience an electrostatic force Fe  ,
Fe  qE

(1)

and a counteracting frictional force Ffr  described mathematically by Stokes Law as:
Ffr  6r

(2)

where η is the viscosity of the background electrolyte,  is the migration velocity,
and r is the Stokes’ radius of the solute. During electrophoretic separation these
forces are equal in magnitude setting up a steady state in which ionic species travel at
a constant velocity.
The velocity is a product of the electrophoretic mobility  an and the applied electric
field

   an  E

(3)

The electrophoretic mobility for a charged species is approximated as

 an  q

6r

(4)

The mobility can be experimentally determined from the migration time (t) of the
solute using the following equation:
 l

Et

10

(5)

From equation 4, larger solutes with smaller charges will have a lower mobility than
smaller solutes with greater charge. Adjustments to the BGE’s pH can affect the
overall charge of the ionic species causing their mobility to increase or decrease
accordingly. Along with this, the addition of buffer additives or change in separation
temperature will affect the viscosity of the BGE resulting in changes to
electrophoretic mobility.
1.2.2. Electroosmotic flow

Movement of solutes within the capillary is not limited to charged molecules.
Neutral solutes migrate within the capillary as the result of the electroosmotic flow.
When the capillary is filled with BGE, a charge develops on the inside wall of the
capillary. By electrostatic attraction, counterions in the BGE absorb on the wall
setting up a double electric layer at the capillary wall-BGE interface. According to a
model proposed by Stern, the double layer is composed of a compact layer of tightly
held ions and a diffuse layer (Giddings, 1969).

11

Figure 3: Simplistic model of a double electric layer.
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Figure 3.
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The electrical potential decreases with increasing distance from the capillary wall.
The potential in the diffuse layer is referred to as the zeta potential (ζ). An imaginary
boundary is present between these layers called the plane of shear Figure 3. As a
result of viscous drag, when an electric field is applied, ions in the diffuse layer break
away at the plane of shear, dragging with them the bulk liquid producing an
electroosmotic flow. It is by EOF that neutral molecules are able to migrate. The
mobility of the EOF is described by:
 EOF 

E
4

(6)

where EOF mobility is directly proportional to the dielectric constant of the solution
(ε), the applied electrical field (E), and the zeta potential (ζ) and inversely
proportional to the viscosity of the BGE (η). If this parameter is not controlled it can
lead to a decrease in separation (Bullock & Yuan, 1991). The apparent mobility of a
charged solute is the sum of the EOF mobility (Eq. 6) and its ionic mobility (Eq. 4).
The EOF mobility is measured experimentally using an uncharged solute.
1.2.3. Selectivity and efficiency

Since the EOF affects the amount of time a solute spends in the capillary,
separation efficiency, selectivity, and resolution are related to the direction and
velocity of the EOF. Unlike laminar flow in liquid chromatography, the
electroosmotic flow has minimal effect on resistance to mass transfer. Therefore, the
theoretical plate count in a capillary is much larger than that of a chromatography
column of the same length.

14

Diffusion occurs during the time t, it takes for a sample zone to travel from the





point of injection to the point of detection. The spatial variance  2 L of the zone is
given by:
 2 L  2DL2 / V

(7)

where D is the diffusion coefficient of the solute, L is the total length of the capillary,
V is the applied voltage, and μ is the apparent electrophoretic mobility of the solute.
The efficiency is expressed by the theoretical plate number (N),
2

NL

(8)

2L

By substituting Eq. (7) into Eq. (8)
N  V

(9)

2D

It can be observed from Eq. (9), that: a) The efficiency can be improved by applying
high voltages; b) Solutes with higher mobilities and low diffusion coefficients will
produce higher plate counts.
The efficiency may be experimentally determined by:
N  5.54t / w 1 / 2 

2

(10)

where t is the migration time and w1/2 the peak at half height. Equation (10) is correct
only for Gaussian peaks. Selectivity is the thermodynamic measure of the differences
in affinity of two ligands for binding to a substrate. The selectivity is given by:
  

 average

 2(1   2 )

(1   2 )

(11)

where μ1 and μ2 are the observed electrophoretic mobilities of each ligand.
Differences in physiochemical properties between solutes determine differences in

15

selectivity. The most important parameter for optimizing the selectivity of charged
solutes is pH (Guan et al., 2012).
1.2.4. Resolution

Resolution is a function of the selectivity (α), migration time (t), and the
separation efficiency (N) (Jones et al., 1990). Resolution is defined according to
selectivity and efficiency by:

 

 


 1/ 2
R s  1  
N  1  N 1 / 2
4   average 
4

(12)

In CE there are many sources that can have adverse effects on resolution.
Electrodispersion occurs when the electric field strength is non-linear along the length
of the capillary. When the voltage drop along the capillary is not linear, samples
travel along the capillary at different velocities causing peak dispersion to occur. A
measurement for the extent of this dispersion is given by the baseline peak width
( w base ),
w base  4

(13)

where σ is the standard deviation. The resolution can be determined from the
migration time (t) by:
Rs 

2( t 2  t 1 ) t 2  t 1

w1  w 2
4

(14)

where w is the baseline width in time. Conductivity differences between the sample
zone and surrounding buffer zones, lead to peak shape distortion. The effects of
electrodispersion are addressed by adjusting the BGE’s ionic strength, sample plug
injection length, and sample concentration.
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1.3. Capillary Electrophoresis for enantioselective analysis
In the experimental set-up chiral separation is induced by the addition of chiral
selectors to the background electrolyte. Upon the application of voltage, enantiomers,
D and L migrate within the capillary interacting with a chiral selector P, forming
drug- selector complexes with equilibrium constants KD and KL :
KD
D  P 
 DP

and

KL
L  P 
LP

(15)

Two enantiomers of a given chiral compound have identical electrophoretic
mobilities in free solution. The resolution of enantiomers is based upon interaction
with the chiral selector. The “three-point interaction model” states that three points of
interaction between the chiral selector and one of the enantiomers is required before
discrimination by the selector is achieved as illustrated in Figure 4 (Davankov, 1998;
Kitawaga & Otsuka, 2011). The molecular interaction between the selector and
enantiomer involves coulomb forces, hydrogen bonding, steric hindrance, π-π
interaction, ion-dipole, dipole-dipole, London dispersion, and dipole-induced dipole
forces. The strongest interaction occurs with the Coulomb force (Kitawaga &
Otsuka, 2011). For separation to be achieved, there are conditions that must be
satisfied: (1) The equilibrium constants for selector-solute binding must be different
for the two enantiomers; (2) There must be significant amounts of both chiral selector
and solute; (3) Equilibration of the enantiomer in and out of the selector, must be
faster than the time scale of separation; (4) Mobilities of complexed and free drug
must be different. The enantiomer in complex with the selector will migrate at a
velocity different from the free enantiomer. This results in measurable differences in
electrophoretic mobility between free and complexed drugs.
17

Figure 4: The three point interaction model. Enantiomer (a) can interact only with

two sites on the chiral selector, while its mirror image enantiomer (b) presents three
groups that match three sites of the selector.
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Figure 4.
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1.3.1. Common chiral selectors

The further development and use of novel chiral selectors are based upon cost,
availability, solvent compatibility, and performance compared to established
selectors. Selectors commonly used in CE chiral separations include cyclodextrins,
micelles, macrocylic antibiotics, and proteins.
1.3.1.1. Cyclodextrins

The majority of chiral CE separations make use of cyclodextrins. Cyclodextrins
are nonreducing oligosaccharides obtained from enzymatic digestion of starch. They
are commonly found in the α-, β-, and γ-conformations, composed of 6, 7, and 8 α(1-4)- linked glucopyranose units, respectively. The α- structure is represented
schematically in Figure 5. Cyclodextrins have hydrophobic internal cavities and
polar groups are on the outside. Drug molecules fit into these cavities forming
inclusion complexes (Schmitt et al., 2002). Formation of inclusion complexes is
influenced by the geometry and size of the drug molecules.
While hydrophobic interactions predominate in the formation of inclusion
complexes, polar interactions also can occur along with hydrogen bonding and Van
der Waals forces. The advantages associated with the use of cyclodextrins are their
water solubility, ionizability, UV transparency, and stability in solution (Ilisz et al.,
2009; Zhang et al., 2012). UV transparency of cyclodextrins is advantageous for
development of CE methods.
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1.3.1.2. Micelles

Micelles are formed when amphiphilic molecules containing both strongly polar
and strongly nonpolar groups, aggregate in aqueous solutions above their critical
micellar concentration. Amphiphilic molecules are frequently composed of a long
nonpolar alkyl chain as the hydrophobic group and a polar head group (charged or
neutral) as schematically represented in Figure 6 for sodium dodecyl sulfate (SDS).
The ionic function of the surfactant hydrates readily, whereas the hydrophobic tail is
intrinsically insoluble. In polar solvents, it is assumed that micelles are spherical in
shape and oriented such that the polar groups are located on the outer zone and the
alkyl groups constitute a hydrophobic core (Masci et al., 2012). The separation
principle in micellar CE represents a hybrid technique based upon both a partitioning
mechanism and electrokinetic migration. It is analogous to chromatography in that
enantiomers are separated based upon residence time differences in the mobile
(aqueous) phase and more stationary (micellar) phase.
Mostly anionic surface-active compounds like SDS have been used for the
analysis of ionic and nonionic compounds (Lin et al., 2004). Cationic surfactants
have been employed for anionic and neutral compounds (Wu et al., 2001). One
important aspect to consider when using a cationic surfactant at high concentration is
the direction of the electroosmotic flow is reversed. Since resolution is improved
when chiral selector and EOF move in opposite directions, separation efficiency may
be adversely affected if experimental methods are not modified to address changes in
EOF.
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Figure 5: Structure of α- cyclodextrin.
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Figure 5.
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1.3.1.3. Macrocylic antibiotics

Macrocyclic antibiotics are a class of antibiotics used in therapy against infections
caused by gram-negative and gram-positive bacteria. Natural and semisynthetic
macrocyclic antibiotics comprise a variety of structural types, which include peptides,
glycopeptides, ansa compounds, and peptide-heterocycle conjugates. A schematic of
an ansa compound is represented in Figure 7. There are acidic, basic, and neutral
types of antibiotics that differ in a number of physicochemical properties that
determine their usefulness for chiral selection. Macrocyclic antibiotics contain
functionalities such as ester, hydroxyl, amide, primary amine and aromatic groups
which are involved in intermolecular interactions with chiral molecules (Armstrong et
al., 1994). The chiral recognition in intermolecular interactions is maintained by
stereogenic centers. The numbers of stereogenic centers in the antibiotics vary,
allowing them to have multiple interactions with chiral molecules.
Macrocyclic antibodies interact with chiral molecules by hydrogen bonding, π-π
interactions, hydrophobic interaction, dipole-dipole, and ionic interactions
(Armstrong& Nair, 1997; Ward & Oswald, 1997). The selectivity of macrocyclic
antibiotics is specific to the charge of the analyte and especially useful for the
separation of acidic chiral analytes. Macrocyclic antibiotics use for the determination
of trace levels of chiral compounds can be hindered by their high UV absorbance.
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Figure. 7: Schematic of an ansa compound. (n ≥ 5)* Where n denotes the number of

atoms bridging the para positions on the molecule.
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Figure 7.
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1.3.1.4. Proteins

Proteins are high molecular weight biopolymers which consist of L-amino acids.
Many uniquely bind a single enantiomer of chiral molecules. Protein chiral
recognition is affected by both charge and hydrophobic interactions. This mode of
CE, utilizing protein as the chiral selector is referred to as affinity capillary
electrophoresis (ACE). There are a number of proteins that have been used to carry
out chiral CE separations. Examples include glycoproteins, enzymes such as
lysozyme, fungal cellulase, as well as cytochrome c (Tanaka & Terabe, 2001). Alpha
(1) acid glycoprotein is one of many glycoproteins found in plasma that is responsible
for the binding of cationic drugs (Li & Lloyd, 1993; Tanaka & Terabe, 1997; Amini
et al., 1997). The enantioselective binding of drugs is influenced by sugar moities
and sialic acid residues. In the case of enzymes, the enzymatically active core is the
dominating site for drug binding (Marle et al., 1993). Although a number of proteins
have been employed, the most extensively studied in chiral CE are bovine serum
albumin and human serum albumin.
1.3.1.4.1. Drug-serum albumin binding

The first study aimed at examining the suitability of CE applications for
measuring drug-plasma protein binding was reported in 1992 (Kraak et al., 1992).
Serum albumin is the most abundant protein in plasma (Fanali, et al., 2012). Bovine
serum albumin (BSA) consists of a single polypeptide chain of 581 amino acid
residues that are folded in a series of α-helices, and further organized into three
domains. The tertiary structure of BSA is stabilized by 17 disulfide bridges. The
warafin-azapropazone site (site I) and the indol-benzodiazepine site (site II) are the
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two major sites in serum albumin for binding drugs (Sudlow, et al., 1976). Figure 8
shows the structure of albumin with different binding sites based upon Protein Data
Bank file, 2BXG. Although both site I and II have been reported to bind aromatic
and heterocyclic ligands site I tends to bind bulky heterocyclic anions (Peters, 1996;
Carter & Ho, 1994). As a result of its ability to accommodate more than one ligand at
a time, site I is described as a large and flexible region (Peters, 1996). By contrast
site II, is smaller, less flexible and more stereospecific binding occurs at this location.
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Figure 8: Albumin binding sites. The structure of albumin is shown with the major

drug binding sites labeled (PDB ID: 2BXG).
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Figure 8.

32

1.4. Factors that reduce tryptophan-serum albumin binding
It is accepted that the pharmacokinetic properties of drugs are influenced by
reversible interactions with serum proteins (McMenamy & Oncley, 1958: Sudlow et
al., 1975). Thus, the enantioselective binding of drugs by serum proteins is of great
importance in the drug development process. Drug enantiomers tend to have
different binding affinities for proteins. Drug binding constants provide quantitative
measures by which drug binding and drug-drug displacement are determined and
possible side effects are checked during preclinical trials (Betts et al., 2010, Rudnev
et al., 2006).
In the presence of competing molecules, the extent of drug binding to serum
proteins is reduced. Site II in serum albumin, is the high affinity binding site for both
L-tryptophan and the non-steroidal anti-inflammatory drug ibuprofen (Sun & Wang,
2012). Ibuprofen and tryptophan are administered in the treatment of migraines. As a
result of limited binding sites for these drugs, if administered concurrently,
competition will exist between ibuprofen and L-tryptophan for binding
(Berezhkovskiy, 2006). Inhibition of binding by one drug to another is a function of
the relative concentrations of each drug, and specificity of binding (Langlois et al.,
2012). There are a number of secondary drug binding sites on serum proteins that
make drug-drug displacement difficult to predict. Strategies to investigate the effects
of ibuprofen on interactions of tryptophan with serum albumin prove vital for
providing insight into the usefulness of certain drug combinations. The displacement
of L-tryptophan from serum albumin by ibuprofen has been studied by ultrafiltration
and other in vitro assays (Basken et al., 2009).
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The ability of proteins to select between optical isomers is attributed to their three
dimensional structure. When protein modification induced by physiological changes
occurs, an alteration of the protein’s native binding efficiency is expected (Oettl &
Stauber, 2007). Non-enzymatic glycation is a major in vivo mechanism that
contributes to structural alteration of albumin. Glycation occurs most often at the Nterminal amino group and the side chains of the lysine residues. It also has been
reported to occur at arginine, cysteine, histidine, and tryptophan residues (Munch et
al., 1999). Glycation of a lysine side chain occurs through the Maillard reaction as
shown in Figure 9. In the initial step of glycation, glucose attaches to free amine
groups of albumin, forming a reversible Schiff base. Through an Amadori
rearrangement a stable fructosamine product is formed. Schiff base and fructosamine
products are the early glycation adducts which can be further modified by
rearrangement, oxidation, polymerization, and cleavage to form irreversible
conjugates called advanced glycation end products (Thornalley, 1999).
The extent of glycation is a function of glucose concentration and protein reaction
time. Associated with the extent of glycation is a change in protein mass and charge.
Knowledge about how glycation effects drug binding may lead to advancement in
both treatment and diagnosis of diseases such as diabetes. Clinical implications of
albumin glycation include drug binding may be altered for example at various stages
of diabetes. In one study the binding of tryptophan by albumin, was found not to be
affected by glycation, while in a different study low levels of glucose were reported
to lower the affinity of albumin to bind (Bohney et al., 1992; Barzegar et al., 2007).
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Figure 9: Formation of glycated albumin.
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Figure 9.
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Studies to investigate the binding capacity of glycated albumin have been done
using equilibrium dialysis, ultrafiltration, and high-performance liquid
chromatography (Bohney & Feldhoff, 1991; Koizumi et al., 1998; Mikulikova et al.,
2005). Disadvantages to using equilibrium dialysis are volume shifts, nonspecific
adsorption to the dialysis apparatus, and Donan effects (Oravcova et al., 1996). A
pitfall to ultrafiltration is the necessity for a large number of data points. The
problematic aspect of high pressure liquid chromatography is the high sample
consumption rate. Contradictory reports have given impetus to further develop
simplistic methods that can provide accurate information for characterizing the effects
of serum albumin glycation on drug binding.
The use of CE as an analytical tool for addressing biochemical questions of
interest is demonstrated in this dissertation by developing methods to characterize the
effects of ibuprofen and glycation of BSA on the enantioselection of chiral drugs.

1.5. HYPOTHESIS
I hypothesize that capillary electrophoresis can be systematically optimized to
develop experimental protocols and associated fundamental models for examining
protein-drug binding and modulation of those interactions through drug-drug
displacement and subtle changes in protein structure.
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Chapter 2
Materials and Methods
2.1. Chemicals
Bovine serum albumin (cat. No. BP671-1), sodium phosphate dibasic (cat. No.
5374-500), phosphoric acid (85%) (cat. No. 7664-38-2), methanol (cat. No. A452SK4), and sodium hydroxide (NaOH) (cat. No. 1310-73-2) were purchased from Fisher
Scientific (Fair Lawn, NJ, USA); D,L-tryptophan (CAS: 54-12-6) was purchased
from ACRŌS Organics (Fair Lawn, NJ, USA); Ibuprofen (cat. No. I-1892), 5-fluoroD,L-tryptophan (cat. No. 154-08-5), deuterium oxide (D2O) (cat. No. 7789-20-0), and
5-hydroxy-D,L-tryptophan (cat. No. 114-03-4) were purchased from Sigma Aldrich
(St. Louis, MO, USA). Sodium phosphate monobasic (cat. No. 4011-1) was
purchased from J.T. Baker, Inc. (Phillipsburg, NJ, USA). D- (+)-glucose (cat.
No.194672) was purchased from MP Biomedicals, LLC (Solon, OH, USA). Solutions
were prepared in deionized water treated using a Water PRO Plus system by
LABCONCO (LABCONCO Corp, Kansas City, MO, USA).

2.2. Instrumentation
2.2.1. Capillary electrophoresis (CE)

An Agilent G1600 HP3D Core CE system (Santa Clara, CA, USA) was employed
for separations. Data acquisition and instrument control were by ChemStation
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software (Agilent, Waldbronn, Germany). Data were exported to Excel (Microsoft,
Redmond, WA, USA) and then further mathematically processed using SigmaPlot 12
(Systat Software, Inc., San Jose, CA, USA) and BOMEM GRAMS/386 software
(ABB Bomem Inc., Québec, Canada) for curve fitting. The separations were
performed in bare fused-silica capillaries (cat. No. G1600-60311) purchased from
Agilent with 48.5 cm total lengths, effective lengths of 40 cm, and internal diameters
of 75µm. New capillaries were rinsed with NaOH (0.3 M) for 30 min, and deionized
water for 30 min, then background electrolyte for 60 min at 920 mbar. When not in
use, capillaries were rinsed with 0.1 M NaOH for 10 minutes, water for 10 minutes,
air for 20 minutes, and stored dry. The capillary temperature was maintained at
25C throughout separations. Samples were injected hydrodynamically using 20 mbar

pressure for 5 seconds.
2.2.2. Mass Spectrometer

Mass spectra were acquired on a Bio-TOF III high resolution mass spectrometer
(Bruker Daltonics, Billerica, MA, USA). Data was acquired by DataAnalysis 3.2
software (Bruker Daltonics, Billerica, MA, USA). Samples were injected into the
mass spectrometer using a Cole Palmer syringe pump (cat. No.74900-05, Vernon
Hill, IL, USA).
2.2.3. Proton Nuclear magnetic resonance

A Varian INOVA 600 NMR spectrometer (Palo Alto, CA, USA) equipped with :
(1) a triple resonance inverse probe (1H/13C/X), (2) a broadband observe probe with
a 13C/1Hdecouple channel (X/13C/1H), (3) an inverse nanoprobe for 1H MAS
spectroscopy in small volumes (40 μl), (4) a variable temperature unit (FTS Systems,
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XR401 air-jet crystal cooler,  40C to + 100C , and (5) a Zymark XP robotics
sample changer.

2.3. Determine relevant parameters for improving enantioselection
and migration time reproducibility
Consecutive runs were made of D,L tryptophan (0.5 mg/ml), chosen arbitrarily for
simplicity, in the presence of 30 μM BSA. Previous studies aimed at assessing
enantioselection of tryptophan enantiomers reported optimized resolution occurs
when there is a concentration of 30 μM BSA in the background electrolyte (Hödl et
al., 2006). Buffer concentration and temperature listed as optimal for BSA binding
employed in HPLC separations were 25 mM sodium phosphate, pH 7.4 at 25°C
(Gilpin et al., 1991). As a result of these findings, initial experiments were carried out
under these conditions. The tryptophan-BSA model was used in this study. Four
separate preconditioning experiments were carried out to investigate the effects of
protein adsorption on enantioselection.
2.3.1. Ohm’s Law plot

To assure joule heating would be minimized, an Ohm’s Law plot was constructed
to determine the buffering capacities of 25 mM, 50 mM, 75mM, and 100 mM sodium
phosphate buffer systems before serum protein addition.
Solution preparation

A concentrated 0.1 M sodium phosphate buffer was prepared by placing 2.62 g of
sodium phosphate monobasic, and 14.42 g sodium phosphate dibasic into a 1L
volumetric flask. To the flask 800 ml of water was added, pH of solution was
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adjusted to 7.4 using phosphoric acid (85%), then additional water was added to bring
final volume to 1 L. The 25 mM, 50 mM, and 75 mM sodium phosphate buffers were
prepared by pipeting 3.75 ml, 7.5 ml, and 11.25 ml of the 0.1 M buffer into separate
volumetric flask, respectively. Each solution was brought to a final volume of 15 ml
with deionized water. Prior to use, buffers were degassed by mixing with a magnetic
stir bar while under vacuum. They were also filtered through a Fisherbrand 0.20 μm
pore size, PTFE filter (Fisher Scientific, Fair Lawn, NJ, USA). Sodium hydroxide
(0.1M) was prepared in deionized water. It was also degassed by stirring and vacuum
suction.
CE instrumental set-up

The instrument settings were as follows: CE MODE, CE; INJECTION BY, No
Injection; Lift Offset: 4 mm, Cassette Temperature, 25°C; CE Conditioning:
Replenish (none), Postconditioning (none), Preconditioning (Use Table); Diode
Array Detector (DAD) Signals: A- 200, B-240, C-260, D- 270, E- 280, and spectrum
store- All in peak, with a threshold of 2.00 mAu; Time Table tab checked voltage,
current, and temperature with a stoptime of 0.20 min; Switch Electric was set to on
with a positive polarity and a voltage ramp of 0 to 30 kV was applied. At the
capillary inlet were vials containing 1 ml of NaOH (0.1M), deionized water, and
sodium phosphate buffer (25 mM - 100 mM). At the capillary outlet were vials
containing 1 ml of sodium phosphate buffers (25 mM -100 mM), deionized water,
and an empty vial for waste.
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Separation method and data acquisition

The following steps were used for constructing the Ohm’s plot for each buffer
system tested: 1) Rinsed capillary 1 minute with NaOH (0.1M) with an applied
pressure of 50.0 mbar; 2) Waited 4 minutes; 3) Rinsed capillary 1 minute with water
with an applied pressure of 50.0 mbar; 4) Rinsed the capillary 1 minute with sodium
phosphate buffer with an applied pressure of 50.0 mbar; 5) Switched on voltage for
2.5 minutes with a ramping time of 1 minute; 6) Recorded the current and voltage.
Data processing

Current and voltage signals were exported as CSV files to Excel (Microsoft,
Redmond, WA, USA). The buffering capacity was evaluated by plotting the current
as a function of applied voltage.
2.3.2. Applied voltage effects on peak shape
Solution preparation

The background electrolyte, 25 mM sodium phosphate containing 30 μM BSA,
pH 7.4, was prepared from a 0.1 M concentrated solution. The 0.1 M concentrated
sodium phosphate solution and 0.1M NaOH were prepared as described in section
2.3.1. The BGE was prepared as follows: 1) Added 0.1188 g of BSA to 15 ml of
0.1 M sodium phosphate buffer, pH 7.4; 2) Removed 3.75 ml of the BSA solution and
placed it into a volumetric flask. 3) Diluted the solution to a final volume of 15 ml
with deionized water. Samples were prepared by dissolving D,L-tryptophan in
deionized water (0.5 mg/ml). The sample plug volume in the capillary was 17.97 nl.
The total capillary volume was 2143 nl. The mole ratio of drug:BSA in the capillary
interacting was 1:2. Prior to use, buffers and samples were degassed by mixing with a
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magnetic stir bar while under vacuum. Buffers and samples were filtered through a
Fisherbrand 0.20 μm pore size, PTFE filter (Fisher Scientific, Fair Lawn, NJ, USA).
CE instrumental set-up

The instrument settings were as follows: CE MODE, CE; INJECTION BY,
Pressure 20 mbar for 5 seconds; Lift Offset: 4 mm, Cassette Temperature, 25°C;
CE Conditioning: Replenish (none), Postconditioning (none), Preconditioning (Use
Table) table set-up is described in the next section below ; DAD Signals: A- 191, B200, C-254, D- 270, E- 280, and spectrum store- All in peak, with a threshold of 2.00
mAu; Time Table tab checked voltage, current, and temperature with a stop time of
30.0 min; Switch Electric was set to on with a positive polarity, constant voltages of
10 kV to 30 kV were applied.
Separation method and data acquisition

To test applied voltage, the CE preconditioning table was configured as follows:
1. FLUSH 3.00 min with NaOH (0.1 M); 2. FLUSH 3.00 min with water; 3. FLUSH
8 min with BGE. The outlet vials for all flushing steps were empty waste vials.
Following preconditioning of the capillaries surface, a constant separation voltage of
10 kV to 30 kV was applied over a 30 minute separation. The migration time of
enantiomers was recorded at each voltage.
Data processing

The 280 nm signal was exported as a CSV file to Excel (Microsoft, Redmond,
WA, USA). The mobility determined from enantiomer migration time and applied
voltage, as described in equation 5. The mobility of analyte was determined first in
BGE void of BSA. The viscosity of the BGE changed upon the addition of BSA. To
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account for changes in BGE viscosity associated with the addition of protein, a
corrected migration time, t drug  t EOF , where t drug and t EOF is the migration time of
the enantiomer and EOF, respectively, was used to create the plot.
To redraw electropharograms, corrected data were saved as text delimited files and
exported to BOMEM GRAMS/386 program for curve fitting. The selectivity was
measured for both enantiomers at each applied voltage. The difference in selectivity
as a function of voltage was plotted.
2.3.3. Sodium hydroxide and water rinse effects on migration time
Solution preparations

The BGE was prepared as described in 2.3.2. The sodium hydroxide was
prepared as described in 2.3.1.
CE instrumental set-up

The CE instrumental set-up was as described in 2.3.2. with the following
modifications: 1) Switch electric was set to on with a positive polarity voltage of 15
kV; 2) preconditioning table set-up is described in the next section below.
Separation method and data acquisition

To test sodium hydroxide -water rinse times, the CE preconditioning table was
initially configured as follows: 1) FLUSH 3.00 min with NaOH (0.1 M); 2) FLUSH
3.00 min with deionized water; 3) FLUSH 8 min with BGE. Flush times with NaOH
(0.1 M) and water were increased by an increment of 3 min every fourth injection, to
a final rinse time of 15 min. The outlet vials for all flushing steps were empty waste
vials. Following preconditioning of the capillaries surface, a separation voltage of
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15 kV was applied for 30 minutes. The migration times of enantiomers and acetone (n
= 4) were recorded.
Data processing

The 280 nm signal was exported as a CSV file to Excel (Microsoft, Redmond,
WA, USA). Fluctuation in migration time associated with change in BGE viscosity
was corrected by subtracting the migration time of acetone. The difference in
migration time of acetone as a function of NaOH/water rinse time between
consecutive injections (n =4) was measured.
2.3.4. Evaluating the selectivity as a function of BGE rinse time
Solution preparations

The BGE and samples were prepared as described in 2.3.2. The sodium
hydroxide was prepared as described in 2.3.1.
CE instrumental set-up

The CE instrumental set-up was as described in 2.3.2. with the following
modifications: 1)Switch electric was set to on with a positive polarity voltage of 15
kV; 2)preconditioning table set-up is described in the next section below.
Separation method and data acquisition

To test BGE rinse times, the CE Preconditioning table was initially configured as
follows: 1) FLUSH 3.00 min with NaOH (0.1 M); 2) FLUSH 3.00 min with
deionized water; 3) FLUSH 8 min with BGE. Flush times with BGE were increased
by an increment of 8 min every fourth injection, to a final rinse time of 32 min. The
outlet vials for all flushing steps were empty waste vials. Following preconditioning
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of the capillaries surface, a separation voltage of 15 kV was applied for 30 minutes.
The migration times of enantiomers and acetone (n = 4) were recorded.
Data processing

Data was processed as described in 2.3.2. with the following modification: The
change in the selectivity as a function of BGE rinse time was measured.
2.3.5. Evaluating the selectivity as a function of wait time
Solution preparations

The BGE and samples were prepared as described in 2.3.2. The sodium
hydroxide was prepared as described in 2.3.1.
CE instrumental set-up

As described in 2.3.2. With the following modifications: Switch electric was set
to on with a positive polarity voltage of 15 kV; preconditioning table set-up is
described in the next section below.
Separation method and data acquisition

To test wait times, the CE Preconditioning table was initially configured as
follows: 1) FLUSH 3.00 min with NaOH (0.1 M); 2) FLUSH 3.00 min with water; 3)
FLUSH 8 min with BGE; 4) WAIT 10 min. Wait times prior to separation voltage
application were increased by an increment of 10 min every fourth injection, to a final
wait time of 60 min. The outlet vials for all flushing steps were empty waste vials.
Following preconditioning of the capillaries surface, a separation voltage of
15 kV was applied for 30 minutes. The migration times of enantiomers and acetone (n
= 4) were recorded.
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Data processing

Data was processed as described in 2.3.2. with the following modification: The
change in selectivity as a function of wait time was measured.
2.3.6. Evaluating the selectivity as a function of sample buffer ionic strength
Solution preparations

The BGE was prepared as described in 2.3.2. The sodium hydroxide was
prepared as described in 2.3.1. Samples were prepared by dissolving tryptophan (0.5
mg/ml) in sodium phosphate buffer, pH 7.4, of ionic strengths 5 mM to 25 mM. All
buffers were prepared from 0.1 M concentrated buffer. Prior to use, buffers and
samples were degassed by mixing with a magnetic stir bar while under vacuum.
Buffers and samples were filtered through a Fisherbrand 0.20 μm pore size, PTFE
filter (Fisher Scientific, Fair Lawn, NJ, USA).
CE instrumental set-up

The CE instrumental set-up was as described in 2.3.2. with the following
modifications: 1) Switch electric was set to on with a positive polarity voltage of 15
kV; 2) preconditioning table set-up is described in the next section below.
Separation method and data acquisition

The CE Preconditioning table was configured as follows: 1. FLUSH 3.00 min to
with NaOH (0.1 M); 2. FLUSH 3.00 min with water; 3. FLUSH 8 min with BGE; 4.
WAIT 10 min. The outlet vials for all flushing steps were empty waste vials.
Following preconditioning of the capillaries surface, a separation voltage of 15 kV
was applied for 30 minutes. The migration times of enantiomers and acetone (n = 4)
were recorded.
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Data processing

Data were processed as described in 2.3.2. With the following modification: The
difference in selectivity as a function of sample buffer ionic strength was measured.

2.4. Capillary electrophoresis applications for studying
competitive binding.
The displacement of L-tryptophan by ibuprofen can be determined by using
ibuprofen as an additive to the BGE (Berezhkovskiy, 2006). The influence of
ibuprofen on the enantioselection of 5-fluoro-D,L-tryptophan and D,L-tryptophan by
BSA was studied. The tryptophan-BSA model was employed.
Solution preparations

For binding constant measurements BGEs containing 0, 10 μM, 15 μM , 20 μM,
30 μM, and 35 μM BSA were employed. The sodium phosphate 0.1M buffer was
prepared as described in 2.3.1. To obtain the desired BSA molar concentrations,
protein was added to 15 ml of 0.1M sodium phosphate, pH 7.4 as following: 10 μM,
0.0396 g; 15 μM, 0.0594 g; 20 μM, 0.0792 g; 30 μM, 0.1188 g; and 35 μM, 0.1386 g.
For competitive binding studies, ibuprofen solution was added to BGE (35 μM) at a
concentration ranging from 0 to 55.3 μM. Samples of D,L-tryptophan and 5-fluoroD,L-tryptophan (0.0225 to 0.54 (mg/ml)) in 8 mM sodium phosphate, pH 7.4. Prior to
use, samples and buffers were degassed and filtered through a Fisherbrand 0.20 μm
pore size, PTFE filter (cat. No. 09-720-7) (Fisher Scientific, Fair Lawn, NJ, USA).
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CE instrumental set-up

The CE instrumental set-up was as described in 2.3.2. with the following
modifications: 1) Switch electric was set to on with a positive polarity voltage of 15
kV; 2) preconditioning table set-up is described in the next section below.
Separation method and data acquisition

The CE Preconditioning table was configured as follows: 1) FLUSH 3.00 min
with NaOH (0.1 M); 2) FLUSH 3.00 min with deionized water; 3) FLUSH 8 min
with BGE; 4) WAIT 10 min. The outlet vials for all flushing steps were empty waste
vials. Following preconditioning of the capillaries surface, a separation voltage of 15
kV was applied for 30 minutes. The migration times of enantiomers and acetone (n =
4) were recorded.
Data processing

Data were processed as described in 2.3.2. with the following modification: The
difference in selectivity as a function of ibuprofen concentration was measured.

2.5. Capillary electrophoresis applications for studying binding
of glycated serum proteins.
Solution preparations

The BGE for control and test experiments were prepared in both deionized water
(H2O) and deuterium oxide (D2O) as described in 2.3.2. D-glucose (14.5 mM) was
added to the test BGE. Samples were prepared as described in 2.3.2. The sodium
hydroxide was prepared as described in 2.3.1. A 50 ml methanol/water (80/20)
solution containing 0.1% trifluoroacetic acid (TFA) was prepared by placing 39.96
ml methanol, 9.99 ml deionized water, and 50 μl TFA in a 50 ml volumetric flask.
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The BGE employed for mass spectral analysis, was prepared as follows: 0.25 ml of
BGE (H2O) was placed into a microcentrifuge tube and diluted with methanol/water
solution to a final volume of 1.0 ml.
Instrumental set-up
Capillary Electrophoresis

The CE instrumental set-up was as described in 2.4.2.
NMR

The instrument was set at the following: 1 H resonance frequency = 600 MHz;
CPMG spin echo pulse sequence (Echo Time, TE = 30 msec). Measurements were
taken at 25°C.
Mass Spectrometry

The instrument settings were as follows: ESI Ionization; Positive Polarity;
Drying Gas Temperature 250°C; sample rate 2 GS/ s; delay time, 25 μs; Capillary, 4
kV; End Plate, 3.5 kV; Cylinder, 2 kV; Digitizer Summing, 500 spectra.
Separation method and data acquisition
Capillary Electrophoresis

Data were acquired as described in 2.4.3.
NMR

Data were acquired over 8 hours using: 1.0 s Relax. Delay; pulse of 34.6 degrees;
Acq. Time 4.0 sec; Width 8,000 Hz.
Mass spectrometry

Mass spectra were recorded using 0.5 ml of BGE (H2O) injected from a 0.5 ml
Gastight syringe (cat. No. 1750, Hamilton Co., Reno, NV, USA) using a flow rate of
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100 μl/hr. Mass spectrum was acquired by setting the Deconvoluted parameters tab
in the DataAnalysis 3.2 software (Bruker Daltonics, Billerica, MA, USA) to the
following: Proteins/Large Molecules; Adduct ions (+H, -H); low mass, 1000 (m/z)
and high mass, 100,000 (m/z); abundance cutoff, 10%; maximum charge, +75.
Data processing
Capillary Electrophoresis

Data were processed as described in 2.3.2. with the following modifications: The
difference in selectivity as a function of glycation extent was measured.
NMR

Data were processed by the following parameters: Line broadening 0.3 Hz; FT
size 65536.
Mass Spectrometry

The number of glucose molecules was determined by the following steps: 1) A
detailed deconvoluted mass was measured for unmodified BSA. Results were
exported to Excel (Microsoft, Redmond, WA, USA) and externally calibrated by
dividing the calculated mass by the literature reported mass for BSA (66.4 kD). The
quotient was used as the calibration constant. 2) The corrected deconvoluted masses
for weeks 1 -3 were determined by dividing the experimentally determined masses for
each by the calibration constant. 3) The mass difference between control BSA and
that for weeks 1-3 was measured. An observed change in BSA mass was used as a
marker for extent of glycation.
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Chapter 3
Results and Discussion
3.1. Determine relevant parameters for improving enantioselection
and migration time reproducibility
Early work focused on elucidating the enantiomeric selectivity of serum albumins
for D- and L- tryptophan, found that the L-enantiomer of tryptophan binds to site II
with an affinity approximately 100 times higher than that of the D-enantiomer
(McMenamy & Oncley, 1958). Investigations by Yang and Hage found that the Denantiomer interacts with site I indirectly, but has no interaction with site II (Yang &
Hage, 1993). The pH and ionic strength of the BGE used in this study is similar to
that approximated under physiological conditions. The native state of the protein and
its molecular function are preserved (Yang & Hage, 1993). Under these conditions
optimum binding of D- and L-tryptophan to bovine serum albumin was found to
occur (Gilpin et al., 1991). Therefore it is of importance to determine the relevant
experimental parameters that are required for optimum enantioselectivity prior to
carrying out further protein-drug binding investigations.
There is little information regarding the exact experimental conditions that are
most relevant for improving chiral recognition by serum proteins in CE applications.
Several factors affect the precision of measurement such as buffer viscosity, sample
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plug length, and applied voltage. The major challenge is the change in EOF over
time caused by protein interactions with the inner surface of the capillary. A
protein’s tendency to adsorb is determined by its primary structure, structural
stability, charge, and size (Nakanishi et al., 2001). Protein adsorption to the capillary
inner surface can be reduced by developing rinsing strategies. Adverse effects from
conductivity can be minimized by using multivalent ions to prepare BGE. Phosphate
buffers, similar to that employed in this study, have been reported to decelerate
adsorption by stabilizing the native structure of the protein (Kurrat et al., 1997). The
aim of this section was to determine the relevant parameters that improve
enantioselection of D- and L-tryptophan by BSA.
3.1.1. Ohm’s Law Plot

Band broadening at higher voltages is caused by Joule heating. This heat is
generated by collisions that occur between solute ions and electrolyte ions. The
extent of heating is based on the conductivity of the BGE and the voltage applied.
Higher ionic strength buffers usually are employed to minimize ion-exchange effects
between charged solute and ionized silanol groups on the capillary wall. High ionic
strength buffers can yield increased heating at constant voltage. The amount of heat
generated using high currents may be beyond the thermostat capabilities of the CE
instrument employed.
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Figure 10: Ohm’s law plots showing the optimum voltage for sodium phosphate

buffers, pH 7.4 (25- 100 mM). ACE conditions: capillary temperature 25°C.

54

Figure 10.
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Although capillaries are cooled on the outer surface, a significant temperature
difference between the BGE in the center and the inner capillary wall can occur
leading to nonuniform temperature gradients within the capillary as well as localized
changes in BGE viscosity. The generation of heat can evaporate BGE solution.
Therefore heat dissipation should be efficient to avoid these adverse effects. Thermal
effects can be circumvented by adjusting the ionic strength of the BGE.
In order to determine the maximum voltage that could be applied without
exceeding the heat removal capacity of sodium phosphate buffers ranging in
concentration from 25 – 100 mM, an Ohm’s law plot was constructed, as illustrated in
Figure 10. Each set of data was fitted by linear regression as represented by the
dashed lines. The regression coefficients for the 25 mM, 50 mM, 75 mM, and 100
mM buffers were 0.996, 0.987, 0.970, and 0.951, respectively. Linearity in the plot
was an indication that the generated heat was being adequately dissipated and
capillary temperature was maintained. Deviation from linearity was an indication that
the thermostatting capability of the system had been exceeded. Linearity was lost for
both the 75 mM and 100 mM buffers at lower applied voltages, in comparison to
those observed for the 25 mM and 50 mM concentrations. In contrast, the 25 mM
buffer exhibited a linear relationship between current and the applied voltage across
the entire range of voltages studied (0- 30 kV), indicating its ability to maintain
capillary temperature at the maximum applied voltage allowed by the instrument.
Subsequently, the 25 mM buffer system was employed for the remaining studies.

56

3.1.2. Applied voltage effects on peak shape

Human serum albumin adsorption to capillary walls decreases in the presence of
an electric field (Yang & Hage, 1994). Mechanisms involved in separating D- and
L- tryptophan depend upon the concentration of protein that is free floating in BGE.
Therefore application of a separation voltage, which minimizes adsorption of protein
to the inner walls of the capillary, will result in improved enantioselection, while
those that do not will cause a loss in enantioselection.
This idea was studied by initially applying separation voltages of 10- 30 kV.
Enantiomer peaks were not observed at applied voltages below 10 kV. Applied
voltages >15 kV produced currents that were above 100 μA. To avoid diffusion
caused by joule heating associated with high currents, voltages above 15 kV were not
used in all later experiments. Electropharograms for D,L-tryptophan at separation
voltages of 10 kV and 15 kV are illustrated in Figure 11 and Figure 12, respectively.
Peak shape distortion was evident at voltages below 15 kV. By using a separation
voltage of 15 kV, peak shape distortion was no longer observed and enantioselectivity
was improved. These results indicated that the stability of absorbed BSA was highest
in the presence of lower applied voltage. This is the same type of behavior seen in
earlier studies (Yang & Hage, 1994).
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Figure 11: Effect of applied voltage on D- and L- tryptophan separation as

represented by peak distortion. BSA concentration in BGE was kept at 30 μM and
D,L-tryptophan amount used was 0.54 mg/ml. ACE conditions: 25°C, 20 mbar
injection for 5s, detection at 280 nm,10 kV separation voltage.
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Figure 12: Effect of applied voltage on D- and L-tryptophan separation as

represented by peak distortion. BSA concentration in BGE was kept at 30 μM and
D,L-tryptophan amount used was 0.54 mg/ml. ACE conditions: 25°C, 20 mbar
injection for 5s, detection at 280 nm, 15 kV separation voltage.
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3.1.3. Sodium hydroxide and water rinse effects on migration time

At physiological pH, both the inner capillary wall and BSA are negatively
charged. Protein-wall interactions primarily are due to H-bonding that occurs
between the carbonyl and amino groups on the protein and the silanol groups on the
capillary wall (van der Veen et al., 2004; Gray, 2004). In albumin the average
density of amino groups that possess H-binding capability is 0.25/nm2 (Kurrat et.al,
1997). Protein adsorption modifies the surface charge of the capillary, contributing to
changes in the mobility of the EOF. This allows for the EOF migration time to serve
as a marker for protein adsorption (Graf et al., 2005). Rinsing the capillary with
additives that cleave H-bonds promotes protein desorption (Docoslis et al., 2001).
Capillary surface regeneration was investigated by rinsing the capillary with
0.1 M NaOH and deionized water at variable times, followed by BGE.
It was found that NaOH rinsing for 3 min at 920 mbar, followed by deionized water
for 3 min at 920 mbar was most effective at controlling shifts in EOF mobility, RSD
0.19%, (n = 4) (Figure 13). The repeatability drastically diminished as the rinse time
increased.
Rinsing the capillary with excessive amounts of sodium hydroxide has been
reported to permit successive saturation of available adsorption sites with protein
residues (Ermakov et al., 1995), permitting protein clusters to pile up within
consecutive runs. Decrease in the EOF migration time repeatability was substantial
for the 9 min rinsing protocol, RSD 12.4%, (n = 4). There was a 3 minute difference
in the EOF migration time between the first and second injections. The rinse time
was increased to 12 minutes and there was an improvement in repeatability,
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RSD 2.4% ( n=4), but repeatability remained lower than that for the 3 min rinsing
protocol. A 3 min rinsing protocol was used in subsequent studies.
The NaOH and water regime was further investigated by rinsing for 3 min with
and without 0.1M NaOH and deionized water between consecutive injections. Each
run included a rinse with BGE only. It was found that the RSD improved from 24.7%
without NaOH- water rinse to 1.84% ( n = 4) with NaOH-water rinse, indicating an
improvement in precision due to the removal of protein from the capillary wall.
Omission of NaOH-water rinsing, led to inverted peaks in the electropharogram
indicating the protein had a higher absorbance at the detection window than D, Ltryptophan (Figure 14). These results indicated that the implementation of a 3 min
rinsing protocol was best for stabilizing the EOF of successive separations.
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Figure 13: The effect of sodium hydroxide/water rinse time on the repeatability of

acetone (neutral marker) migration time in the presence of 30 μM BSA. ACE
conditions: 25°C, 20 mbar injection for 5s, detection at 280 nm, 15 kV separation
voltage.
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Figure 13.
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Figure 14: D,L-tryptophan (0.54 mg/ml). ACE conditions: 25 mM sodium

phosphate, pH 7.4, 30 µM BSA, 25°C, 20 mbar injection for 5s, 15 kV, detection at
280 nm. 0 min NaOH-water rinse between injections. Electropharogram obtained
directly from ChemStation software (Agilent, Waldbronn, Germany) without further
data processing.

66

Figure 14.
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3.1.4. Evaluating selectivity as a function of BGE rinse time

To examine how the inherent tendency of proteins to absorb onto the capillary
wall affects enantioselectivity of tryptophan by BSA, the capillary was rinsed with
BGE for 6 – 32 minutes using 920 mbar pressure. Representative electropharograms
are shown in Figures 15 – 18, for 8, 16, 24, and 32 minute rinse protocols,
respectively. Selectivity, α, was calculated as a function of BGE rinse time for four
separate injections. Subsequently, a plot of the average selectivity versus BGE rinse
time was made (Figure 19) and fitted using a fourth-order polynomial, which yielded
a regression coefficient of 1. The first-derivative curve of the selectivity with respect
to BGE rinse time was plotted and appears in Figure 20.
The average selectivity (n = 4) for the 6 min, 8 min, 16 min, 24 min, and 32 min
rinse times were 1.0  10 2 , 1.2  10 2 , 8.3  10 3 , 1.4  10 3 , and 0, respectively.
Based upon the amount of protein adsorbed, a non-uniform distribution of the ζpotential along the capillary occurred (Ren & Li, 2001). Differences in the ζpotential led to changes in the EOF mobility thereby diminishing selectivity. To
determine if the EOF mobility increased between rinsing protocols, the mobility of
acetone (neutral marker) was measured at each rinse time. Increase in the EOF
mobility was observed (Figure 21). These results were consistent with changes in the
charge density on the surface of the capillary. Dissolved ions in the diffuse layer
moved at a different velocity between each rinsing protocol (refer to Figure 3).
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Figure 15: Electropharogram of D, L- tryptophan (0.54 mg/ml) separation after

rinsing the capillary for 8 min with BGE prior to applying the voltage. ACE
conditions: 25 mM sodium phosphate, pH 7.4, 30 µM BSA, 25°C, 20 mbar injection
for 5s, 15 kV, detection at 280 nm.
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Figure 16: Electropharogram of D, L- tryptophan (0.54 mg/ml) separation after

rinsing the capillary for 16 min with BGE prior to applying the voltage. ACE
conditions: 25 mM sodium phosphate, pH 7.4, 30 µM BSA, 25°C, 20 mbar injection
for 5s, 15 kV, detection at 280 nm.
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Figure 17: Electropharogram of D, L- tryptophan (0.54mg/ml) after rinsing the

capillary for 24 min with BGE prior to applying the voltage. ACE conditions: 25 mM
sodium phosphate, pH 7.4, 30 µM BSA, 25°C, 20 mbar injection for 5s, 15 kV,
detection at 280 nm.
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Figure 18: Electropharogram of D, L- tryptophan (0.54mg/ml) after rinsing the

capillary for 32 min with BGE prior to applying the voltage. ACE conditions: 25 mM
sodium phosphate, pH 7.4, 30 µM BSA, 25°C, 20 mbar injection for 5s, 15 kV,
detection at 280 nm.
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Figure 18.
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Figure 19: Selectivity versus BGE rinse time. ACE conditions: 25 mM sodium

phosphate, pH 7.4, 30 µM BSA, 25°C, 20 mbar injection for 5s, 15 kV, detection at
280 nm. Equation of the 4th order polynomial fitting (solid line): y = -1.6044E-07x4 +
1.5587E-05x3 - 5.1466E-04x2 + 6.1121E-03x - 1.1095E-02, R2 = 1.
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Figure 20: First derivative of selectivity as a function of BGE rinse time.
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Figure 21: Electroosmotic flow rate as a function of BGE rinse time, measured by

the mobility of acetone.
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Resolution diminished in cases where the EOF was too fast, due to the solute’s
inability to stack into uniformed zones within the capillary (Towns & Regnier, 1992;
Tran et al., 2005). Increased concentrations of protein in the capillary promote
environments for protein aggregation, thus leading to dispersion within the sample
plug (Malmsten, 1998; Ding et al., 2005; Herr et al., 2000). The effects of rinsing the
capillary with the BGE for a duration less than or equal to 8 minutes were negligible
on selectivity. Subsequently, remaining experiments were carried out rinsing the
capillary for 8 minutes.
3.1.5. Evaluating selectivity as a function of wait time

Prior to adsorption, proteins approach solvent regions directly adjacent to the
inner surface of the capillary (Towns & Regnier, 1992). Based upon theory, the
selectivity is expected to diminish with increased BGE rinsing time. However, the 8
min rinsing protocol gave the maximum selectivity not the 6 min rinsing protocol. To
gather an understanding of this process and determine the effects of protein diffusion
on selectivity, following the 8 minute capillary flush with BGE, a wait step was
inserted into the rinsing protocol. During this wait step, the BGE was left at a
standstill in the capillary for 10- 60 minutes prior to the application of voltage.
Representative electropharograms are shown in Figures 22– 24, for 10, 40, and 60
minute wait periods, respectively.
Selectivity was calculated as a function of wait time for four separate injections.
Subsequently, a plot of the average selectivity versus wait time was made (Figure 25)
and fitted using a fourth-order polynomial, which yielded a regression coefficient of
1. The first-derivative curve of the selectivity with respect to wait time was plotted
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and appears in Figure 26. The average selectivity (n = 4) for the 10 min, 20 min, 30
min, 40 min, and 60 min wait times were 2.8  10 2 , 2.4  10 2 , 1.9  10 2 , 1.1  10 2 ,
and 1.0  10 2 , respectively.
It is assumed that upon initial filling of the capillary, the concentration of charged
ions in the BGE (i.e. protein) is much higher in the center of the capillary, than near
the wall. During the wait step, charged ions in the BGE diffuse from the region of
high concentration in the center of the capillary, to regions of lower concentration
towards the wall. Since the chiral recognition of tryptophan decreases as the
concentration of serum protein at the wall increases, enantioselection changes can
serve as a marker for protein diffusion (Yang & Hage, 1994).
A pronounced decrease in selectivity was observed as a function of wait time.
The effects of protein diffusing away from the central portion of the capillary further
supported that observed with BGE rinse time. Differences in the ζ-potential along the
capillary that occurred as the concentration of protein at the wall increased led to
changes in the EOF mobility that diminished selectivity.
The fore mentioned results indicated that protein diffusion should be limited in
the capillary prior to separation. It was expected that wait times below 10 minutes
would result in higher selectivity. The 2.3  10 2 (n = 4) average selectivity measured
without a wait step was 16% lower than the 10 min wait step selectivity. This
suggested that controlled protein diffusion could improve chiral recognition. A 10
minute wait step was incorporated into subsequent rinsing protocols.
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Figure 22: 10 minute wait. D,L-tryptophan (0.54 mg/ml). ACE conditions: 25 mM

sodium phosphate, pH 7.4, 30 µM BSA, 25°C, 20 mbar injection for 5s, 15 kV,
detection at 280 nm. The capillary was rinsed for 8 minutes with background
electrolyte solution prior to wait period.
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Figure 23: 40 minute wait. D,L-tryptophan (0.54 mg/ml). ACE conditions: 25 mM

sodium phosphate, pH 7.4, 30 µM BSA, 25°C, 20 mbar injection for 5s, 15 kV,
detection at 280 nm. The capillary was rinsed for 8 minutes with background
electrolyte solution prior to wait period.
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Figure 24: 60 minute wait. D,L- tryptophan (0.54 mg/ml). ACE conditions: 25 mM

sodium phosphate, pH 7.4, 30 µM BSA, 25°C, 20 mbar injection for 5s, 15 kV,
detection at 280 nm. The capillary was rinsed for 8 minutes with background
electrolyte solution prior to wait period.
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Figure 25: Selectivity versus wait time. ACE conditions: 25 mM sodium phosphate,

pH 7.4, 30 µM BSA, 25°C, 20 mbar injection for 5s, 15 kV, detection at 280 nm.
The capillary was rinsed for 8 minutes with background electrolyte solution prior to
each wait period. The equation of the 4th order polynomial fitting (solid line):
y = 1.3287E-08x4 - 1.1936E-06x3 + 2.6123E-05x2 - 4.7843E-04x + 3.0905E-02,
R2 = 1.
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Figure 26: First derivative of selectivity as a function of wait time.
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3.1.6. Evaluating selectivity as a function of sample buffer ionic strength

The voltage along the capillary is assumed to be constant, when it is filled only
with BGE. When solutes of different mobilities are drawn into the capillary, the
solutes will separate into zones, according to their relative mobilities (Equation 5).
Each of these solute zones is surrounded by a zone of BGE, and the voltage along the
capillary is no longer constant. According to circuit theory, where
V = IR

(16)

and V is the applied voltage, I is the current, and R is the resistance, conductivity
differences between zones will determine the magnitude of voltage experienced in
that zone. The voltage will be low in zones of high mobility solute and high in zones
of low mobility solute. The local field strength described by:

V/L

(17)

where V is the applied voltage and L is the total length of the capillary, will therefore
be different in the solute zone based upon the mobility. Changes in the local field
strength with respect to that of the surrounding BGE can lead to diffusion through
electromigration dispersion (Swedberg, 1990). The effects of electrodispersion can
be minimized by decreasing the mobility difference between that of the solute and the
BGE ions. This can be carried out by adjusting the concentration of the BGE, of the
sample buffer, or both. Increasing the concentration of the BGE can lead to band
broadening due to Joule heating if the conductivity of the BGE is high. For this
reason, only the effect of the sample buffer concentration was examined in this
section.
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Tryptophan samples were prepared in sodium phosphate buffer, pH 7.4, at a
concentration of 5 – 25 mM. The effects of electrodispersion were assessed by
measuring the selectivity as a function of sample buffer ionic strength for four
separate injections. Representative electropharograms are shown in Figures 27-30,
for the 5 mM, 8 mM, 15 mM, and 25 mM sample buffer concentrations, respectively.
Subsequently, a plot of the average selectivity versus sample buffer ionic strength
was made (Figure 31) and fitted using a third-order polynomial, which yielded a
regression coefficient of 1. The first-derivative curve of the selectivity with respect to
sample buffer ionic strength was plotted and appears in Figure 32. The average
selectivity (n = 4) for the 5 mM, 8 mM, 15 mM, and 25 mM concentrations were
9.95  10 3 , 1.03  10 2 , 1.03  10 2 , and 8.74  10 3 , respectively.
The slope of the first derivative plot indicated that the enantioselection decreased
as the sample buffer concentration increased, suggesting the difference in the
mobilities of tryptophan and the BGE increased with buffer concentration. The
maximum average selectivity was the same for samples prepared in 8 mM and 15
mM sodium phosphate. Although these values were the same, the RSD between
consecutive injections was 0.03 for the samples prepared in the 8 mM buffer and 0.24
for the samples prepared in the 15 mM buffer. This indicated the variability in
electrophoretic mobility was higher between consecutive injections for samples
prepared in the 15 mM buffer. This also suggested higher variability between the
sample plug mobility and the BGE mobility when samples were prepared in 15 mM
sodium phosphate. Therefore the 15 mM buffer was not employed in subsequent
studies.
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Figure 27: D,L-tryptophan (0.54mg/ml) prepared in 5 mM sodium phosphate, pH

7.4. ACE conditions: 25 mM sodium phosphate, pH 7.4, 30 µM BSA, 25°C, 20 mbar
injection for 5s, 15 kV, detection at 280 nm.
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Figure 28: D,L-tryptophan (0.54mg/ml) prepared in 8 mM sodium phosphate, pH

7.4. ACE conditions: 25 mM sodium phosphate, pH 7.4, 30 µM BSA, 25°C, 20 mbar
injection for 5s, 15 kV, detection at 280 nm.
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Figure 29: D, L-tryptophan (0.54mg/ml) prepared in 15 mM sodium phosphate, pH

7.4. ACE conditions: 25 mM sodium phosphate, pH 7.4, 30 µM BSA, 25°C, 20 mbar
injection for 5s, 15 kV, detection at 280 nm.
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Figure 30: D,L-tryptophan (0.54mg/ml) prepared in 25 mM sodium phosphate, pH

7.4. ACE conditions: 25 mM sodium phosphate, pH 7.4, 30 µM BSA, 25°C, 20 mbar
injection for 5s, 15 kV, detection at 280 nm.
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Figure 31: Selectivity versus sample buffer concentration. ACE conditions: 25 mM

sodium phosphate, pH 7.4, 30 µM BSA, 25°C, 20 mbar injection for 5s, 15 kV,
detection at 280 nm. The equation of the 3rd order polynomial fitting (solid line):
y = 9.7225E-08x3 - 1.4028E-05x2 + 2.8471E-04x + 8.8652E-03, R2 = 1.
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Electrodispersion caused by mismatched solute and BGE mobility will lead to
detected peak tailing or fronting as a result of the solute moving slower or faster than
the bulk liquid, respectively. The shape of the detected peaks at both the 5 mM and 8
mM sample concentrations presented peak tailing, which suggested that the
tryptophan zone was moving slower than the BGE; however the extent of tailing at 8
mM was less than that observed at 5 mM. This indicated that the conductivity in the
sample zone increased with ionic strength, and caused the tryptophan ions to migrate
faster in the capillary.
The effect of electrodispersion on enantioselection was negligible when the
concentration of the sample buffer was no more than three orders of magnitude lower
than the BGE 25 mM concentration. This was in agreement with previously reported
studies (Bruin et al., 1989). As a result, subsequent studies were carried out using
samples prepared in 8 mM sodium phosphate, pH 7.4.
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3.2. Capillary electrophoresis applications for studying
competitive binding
3.2.1. Determining sample concentration

In CE both the protein and the protein-drug complex are under a voltage current
that may change their shapes, leading to the generation of new binding sites or
modification of existing binding sites. As a result, the optimized conditions from
section 3.1 were retested on a new capillary and a BSA concentration of 35 μM in the
BGE improved baseline separation. Therefore it was used in subsequent experiments.
In studies using CE it is assumed that the solute’s mobility is independent of the
solute’s initial sample concentration (Bose et al., 1997; Yang et al., 1996; El-Hady, et
al., 2010). As shown in Figure 33 for tryptophan (Tryp) and 5- fluoro-tryptophan, the
mobility shift of the L-enantiomer initially increases as the concentration of drug is
increased. A noticeable change in mobility occurred at concentrations greater than 0.9
mg/ml. This suggests that tryptophan concentrations within the range of 0.1 mg/ml
and 0.9 mg/ml can be used for binding studies. As a result of the D-enantiomer not
forming a drug-protein complex with BSA, its mobility shift for both drug molecules
was essentially unchanged.
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Figure 33: Mobility shifts of D,L-tryptophan and 5-fluoro-D,L-tryptophan as a

function of tryptophan and 5-fluoro-tryptophan concentrations, respectively. For both
(a) D ( ), L ( )-tryptophan and (b) 5-fluoro-D( ), L ( )-tryptophan the
concentration of BSA in the background electrolyte was held constant at 35 µM and
the sample concentrations employed were 0.1, 0.2, 0.4, 0.9, 1.3, 2.2, and 2.6 (mg/ml).
ACE conditions: 15 kV, 25°C, injection at 20 mbar for 5 s, and detection at 280 nm.
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These observed results can be elucidated by assuming a 1:1 drug-protein complex
model. In isotropic conditions enantiomers exhibit the same behavior. The key factor
required for enantiomeric separation is the presence of a protein chiral selector in the
BGE. Representative electropharograms of D,L-tryptophan and 5-fluoro-D,Ltryptophan in BGE void of BSA are shown in Figures 34 and 35, respectively. Under
conditions in which enantiomer-protein interaction is blocked separation will not
occur. As the concentration of drug injected into the capillary is increased, the
number of drug saturated protein molecules also increases occupying all available
binding sites. Concentrations above optimum range result in non-linear isotherm
conditions that adversely affect separation efficiency.
Separations under nonlinear isotherm condition will produce changes in the
mobility shift, leading to diminished baseline resolution, and distortion of the binding
enantiomer peak shape as represented in Figure 36 for D,L-tryptophan. The Denantiomer peak maintains its Gaussian shape, while the L-enantiomer peak tails. To
maintain continuity between drug samples and utilize drug concentrations that would
not adversely affect the precision of CE measurements, 0.22 mg/ml (1 mM) was
employed for subsequent studies. The final molar ratio of tryptophan:BSA in the
capillary for subsequent studies was 1:4.
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Figure 34: D,L-tryptophan, 0.22 mg/ml (1mM), run in 25 mM sodium phosphate,

pH 7.4, void of BSA. ACE conditions: 15 kV, 25°C, injection at 20 mbar for 5 s, and
detection at 280 nm.

114

Absorbance (Au)

Figure 34.

3.8

4.0

4.2

4.4

4.6

Migration Time (min)

115

4.8

5.0

5.2

Figure 35: 5-fluoro-D,L-tryptophan, 0.22 mg/ml (1mM), run in 25 mM sodium

phosphate, pH 7.4, void of BSA. ACE conditions: 15 kV, 25°C, injection at 20 mbar
for 5 s, and detection at 280 nm.
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Figure 36: Changes in peak shape due to nonlinear isotherm conditions. BSA

concentration was held to 35 μM. D,L-tryptophan sample concentrations used were
0.1 mg/ml, 0.4 mg/ml, and 0.9 mg/ml. ACE conditions: 15 kV, 25°C, injection at 20
mbar for 5 s, and detection at 280 nm.
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3.2.2. Separation selectivity in the presence of ibuprofen

Differences in enantiomer affinity for a given phase are measured by
selectivity  k 2  . The variables k2 and k1 are the retention factors for enantiomer 2
 k1 
and enantiomer 1, respectively. The separation selectivity can be well characterized
with the relative mobility difference between enantiomers by Eq.11 (Chankvetadze,
1997; Blaschke & Chankvetadze, 2003).
In initial experiments selectivity was measured in BGE void ibuprofen. As
reported in literature, the selectivity of BSA for 5-fluoro-D,L-tryptophan was
approximately two times greater than that for D,L-tryptophan, 3.4  10 2 (n = 4)
and 1.6  10 2 (n = 4), respectively (Tittlebach & Gilpin, 1995). The higher selectivity
of 5-fluoro-D,L-tryptophan can be ascribed to differences in hydrophobicity between
derivatives. It was also reported that 5-fluoro-tryptophan has two chemically distinct
binding sites on serum albumin (Gerig & Klinkenborg, 1980). The displacement of
tryptophan was studied by determining the selectivity value for tryptophan derivatives
in the presence of ibuprofen in the BGE. Ibuprofen was added to the BGE at
concentrations of 5.5 μM, 22.1 μM , 33.2 μM, 44.2 μM , and 55.3 μM . These
concentrations resulted in displacer:BSA molar ratios of 1:6, 1:1.6, 1:1, 1.3:1, and
1.6:1, respectively. The selectivity decreased initially for both derivatives, until the
displacer:BSA molar ratio reached 1:1, Figure 37.
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Figure 37: Separation selectivity of BSA for 5-fluoro-D,L-tryptophan ( ) and

D,L-tryptophan ( ) as a function of ibuprofen [Ibu] concentration in the background
electrolyte. Serum protein concentration was held at 35 μM. The concentration of
ibuprofen added to the background electrolyte was 0, 5.5, 22.1, 33.2, 44.2, and 55.3
μM, respectively. ACE conditions: 15 kV, 25°C, injection at 20 mbar for 5 s, and
detection at 280 nm. The standard error in the selectivity is shown for each individual
concentration of ibuprofen.
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The change in selectivity, defined as the difference between the highest and
lowest calculated selectivity value, for D,L-tryptophan was 8.2  10 3 and 5-fluoroD,L-tryptophan 6.4  10 3 . At molar ratios in which BSA was in excess, ibuprofen
appeared to bind mainly to its primary sites on the protein. Diminished selectivity
under these conditions showed that the presence of ibuprofen blocked BSA from
binding L-tryptophan. Representative electropharograms are shown in Figures 38 and
39 for D,L-tryptophan and 5-fluoro-D,L-tryptophan both with 22 μM ibuprofen in the
BGE. Baseline separation was still observed for 5-fluoro-D,L-tryptophan. This
suggested that the affinity of 5-fluoro-D,L-tryptophan binding to BSA was higher
than that for D,L-tryptophan. The binding constants were measured for each analog.
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Figure 38: Electropharogram of D,L-tryptophan (0.22 mg/ml) at a ibuprofen:BSA

molar ratio of 1.6:1 (22 μM ibuprofen). The serum protein concentration was held at
35 μM. ACE conditions: 15 kV, 25°C, injection at 20 mbar for 5 s, and detection at
280 nm.
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Figure 39: Electropharogram of 5-fluoro-D,L-tryptophan at a ibuprofen:BSA molar

ratio of 1.6:1 (22 μM ibuprofen). The serum protein concentration was held at 35 μM.
ACE conditions: 15 kV, 25°C, injection at 20 mbar for 5 s, and detection at 280 nm.
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3.2.3. Measuring the binding constant

These observed differences in binding between analogs were elucidated by
assuming a 1:1 drug-protein complex model,
Ka

E + P  EP

(17)

K a  EP

(18)

EP

where K a , [E], [P], and [EP], denote the association constant, and the molar
concentrations of drug, protein, and drug-protein complex, respectively.
In this model, the effective mobility of the drug,  eff , is described as
   
       EP
 eff   E   E   EP   EP    E 

E 
EP 
E
EP
E
EP














 

(19)

The mobility of free (  E ) and bound (  EP ) drug is weighted by their molar fractions
() . The capacity factor, referred to as the retention factor in some cases, describes
the ratio of bound to free drug. The retention factor, k, is mathematically defined by
(Ostergaard, 2007):
k  [EP]

[E ]

  EP   E

E  0

 K a [P]

(20)

where μEP, μE, and μ0, are the mobilities of the bound drug, the free drug, and the drug
without protein in the BGE. From Equation 20, the binding constant can be
experimentally determined. In this study, the mobilities of the L-enantiomer and the
D-enantiomer were used to measure μEP and μE, respectively. The retention factors for
5-fluoro-D,L-tryptophan and D,L-tryptophan were measured in a BSA concentration
range of 10 – 35 μM.
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Figure 40: Binding constant estimates for 5-fluoro-D,L-tryptophan and D,L-

tryptophan to BSA (10- 35 μM). (a) Retention factor versus BSA concentration
binding plot for 5-fluoro-tryptophan. Equation of the linear fitting: y = 523.14x +
.0013, R2 = 0.95; (b) Retention factor versus BSA concentration binding plot for
tryptophan. Equation of the linear fitting: y = 198.84x + 0.0019, R2 = 0.93.
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The binding constant of 5-fluoro-tryptophan with BSA was 523.14 μM-1 with a
correlation coefficient of 0.95. The binding constant of tryptophan with BSA was
198.84 μM-1 with a correlation coefficient of 0.93. Plots are shown in Figure 40. The
results demonstrated that 5-fluoro-tryptophan had a larger affinity to serum albumin
than that of tryptophan. Thus the difference in selectivity of BSA for 5-fluoro-D,Ltryptophan and D,L-tryptophan in the presence of ibuprofen was due to the higher
binding affinity of the fluoro-analog.
The binding constant determined for L-tryptophan from the CE method agreed
with the value of a previous NMR study under similar experimental conditions
reported to be 230 ± 90 μM-1 (Fielding et al., 2005). Differences in buffer ionic
strength and temperature fluctuation, may have contributed to the wide range of
values reported across laboratories for tryptophan-BSA binding studies.
3.2.4. Measuring selectivity by preformed displacer-protein binary complexes

With the protein free floating in solution, drug-protein interaction is variable.
Such conditions may require higher levels of displacer before effects are observed.
Separations with preformed displacer-protein complexes provide a direct approach to
characterize drug-drug displacement (Li et al., 2011). In a separate experiment using
D,L-tryptophan because of its marked change in selectivity, ibuprofen was
equilibrated with BSA at a displacer:BSA molar ratio of 1:7 for two hours and 4 .5
hours before measurements were taken to establish preformed ibuprofen-BSA binary
complexes in the BGE.
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3. 3. Capillary electrophoresis applications for studying binding
of glycated serum proteins.
3.3.1. Characterization of extent of glycation
Capillary Electrophoresis

Capillary electrophoretic analysis of intact BSA in sodium phosphate buffer, pH
7.4 offered an incomplete separation of modified proteins. The incomplete separation
could have been caused by proteins sticking to the capillary wall. At physiological
pH, protein absorption to the capillary may be pronounced (Graf et al., 2005).
Modification of BSA by glucose rearranged the separation profile, such that the
number of peaks increased over time (Figure 41). The presence of these peaks in the
electropharogram suggested there were a variety of new products forming during the
modification process. The number of new products formed increased with incubation
time.
Mass Spectrometry

To test the applicability of the capillary electrophoretic data, the mass was
evaluated for unmodified and modified BSA. The molecular weight of the
unmodified BSA was found to be approximately 66, 438 Da. Consistent with
previous reports, the masses of modified BSA derived from incubation with glucose
were found to increase with increasing incubation time (Schmitt, et al., 2005).
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Figure 41: CE/UV peak profiles of unmodified and modified BSA in 25 mM sodium

phosphate at pH 7.4. Unmodified BSA (A), BSA modified by glucose for 1 week
(B), BSA modified by glucose for 2 weeks (C), BSA modified by glucose for 3 weeks
(D). All incubations were carried out at 25°C. ACE conditions: 25°C, 20 mbar
injection for 5s, 15 kV, detection at 280 nm.
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The highest mass of BSA was measured for the 3 week glucose incubation. The
data from the electrophoretic characterization earlier were supported by the mass
spectrometric results. The increase in molecular weight induced by glycation
corresponds to the attachment of glucose units to the amino residues of the protein
(Rondeau & Bourdon, 2011). The number of glucose units bound to the protein was
deduced from the mass difference between the unmodified and modified protein. The
maximum number of glucose units added after one, two and three weeks of
incubation were 9, 70, and 76, respectively. The masses of all protein samples for
weeks 1 – 3, along with the approximate number of glucose molecules added to each
newly glycated BSA are given in Tables I- III.
Nuclear Magnetic Resonance

The 1H-NMR spectrum of unmodified BSA showed no peaks in the spectral
region at ~ 5.0 to 5.55 ppm studied. The 1H –NMR of modified BSA incubated for 3
weeks in D-glucose consisted of an envelope of peaks. Notable were the resolved
doublets at 5.24 ppm and 5.50 ppm. Based on the available data in the literature
( Bubb, 2003; Cui et al., 2007), the resonance at 5.24 ppm was attributed to protonproton (JHH) coupling in free α-glucose. There was a large amount of free glucose in
the sample, which resulted in the signal going off scale in the plot. From this large
amount of free glucose two Carbon-13 satellite signals on either side of this main
peak were observed, whose combined intensities were 1.1 % of the main peak. The
resonance from the 1H-NMR spectrum at 5.50 ppm indicated glucose was linked to
BSA through a glycosidic bond (Figure 42) (Bao et al., 2012). This verified protein
structural modification.
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Table I: Data from mass spectrometric analysis of unmodified and modified BSA

after a 1 week incubation in 14 mM D-glucose at 25°C. The modified BSA with the
highest number of glucose molecules bound is highlighted. The concentration of
BSA was 35 μM.
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Table I.

Mass
BSA

66438

Mass of
Glycated
BSA
66755

Mass
Difference

317

Added
Glucose
Molecules
2

66888

450

2

67674

1236

7

67080

642

4

67703

1265

7

67871

1433

8

67399

961

5

68094

1656

9

67387

949

5
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Table II: Data from mass spectrometric analysis of unmodified and modified BSA

after a 2 week incubation in 14 mM D-glucose at 25°C. The modified BSA with the
highest number of glucose molecules bound is highlighted. The concentration of
BSA was 35 μM.
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Table II.

Mass
BSA
66438

Mass of
Glycated
BSA
66755

Mass
Difference
317

Added
Glucose
Molecules
2

78808

12370

69

66888

450

2

76135

9697

54

69294

2856

16

79132

12694

70

72732

6294

35

67674

1236

7

78212

11774

65

74747

8309

46
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Table III: Data from mass spectrometric analysis of unmodified BSA and modified

BSA after a 3 week incubation in 14 mM D-glucose at 25°C. The modified BSA with
the highest number of glucose molecules bound is highlighted. The concentration of
BSA was 35 μM.
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Table III.

Mass
BSA

66438

Mass of
Glycated
BSA
66600

Mass
Difference

162

Added
Glucose
Molecules
1

80067

13629

76

70930

4492

25

67760

1322

7

71409

4971

28

78433

11995

67

75313

8875

49

80134

13696

76

74435

7997

44

66755

317

2
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Figure 42: This is a plot of the spectral region at ~ 5.0 – 5.55 ppm showing signals

from the H1 proton (shown in red) on α-D-glucose. The red spectrum is that of the
unmodified BSA (control). The black spectrum is that of modified BSA after a 3
week incubation in 14 mM D-glucose at 25°C.
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Figure 42:

α-D-glucose

143

3.3.2. Chiral recognition of glycated BSA

The chiral recognition of tryptophan analogs by BSA was altered by the extent of
glycation. Representative electropharograms for D,L-tryptophan, 5-fluoro-D,Ltryptophan, and 5-hydroxy-D,L-tryptophan are shown in Figures 45- 47, respectively.
The selectivity was calculated for four separate injections of D,L- tryptophan and 5fluoro-D,L-tryptophan. It was not possible to separate 5-hydroxy-D,L-tryptophan by
unmodified or modified BSA as previously reported (Hödl et al., 2006). As a result,
the changes in the 5-hydroxy-D,L-tryptophan peak area were measured for
subsequent weeks and used to approximate changes in its chiral recognition by BSA
as follows:
 Area n 1
  100


Area
n 


(21)

where n denotes the week(s) of incubation in D-glucose solution.
Glycation of BSA altered the chiral recognition of D,L-tryptophan, 5-fluoro-D,Ltryptohan, and 5-hydroxy-D,L-tryptophan after one week. The decline in
enantioselection was most pronounced for D,L-tryptophan at 0.051 (Figure 45). The
selectivity for 5-fluoro-D,L-tryptophan declined by 0.032 and the peak area of 5hydroxy-D,L-tryptophan decreased by 13.4% (Figure 47, 49). The chiral recognition
continued to decline after week 2 for both D,L-tryptophan and 5-hydroxy-D,Ltryptophan, however that of 5-fluoro-D,L-tryptophan increased. Although the trend in
decreased enantioselection reversed for all analogs after three weeks, chiral
recognition did not return to its starting values, (Figures 46, 48, and 50).
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Figure 43: D,L-tryptophan (0.22 mg/ml) binding by unmodified BSA (A) and 1 week

modified BSA (B). The serum protein concentration was held at 35 μM. ACE
conditions: 15 kV, 25°C, injection at 20 mbar for 5 s, and detection at 280 nm.
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Figure 44: D,L-tryptophan (0.22 mg/ml) binding by 2 week modified BSA (A) and 3

week modified BSA (B). The serum protein concentration was held at 35 μM. ACE
conditions: 15 kV, 25°C, injection at 20 mbar for 5 s, and detection at 280 nm.
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Figure 45: 5-fluoro-D,L-tryptophan (0.22 mg/ml) binding by unmodified BSA (A)

and 1 week modified BSA (B). The serum protein concentration was held at 35 μM.
ACE conditions: 15 kV, 25°C, injection at 20 mbar for 5 s, and detection at 280 nm.
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Figure 46: 5-fluoro-D,L-tryptophan (0.22 mg/ml) binding by 2 week modified BSA

(A) and 3 week modified BSA (B). The serum protein concentration was held at 35
μM. ACE conditions: 15 kV, 25°C, injection at 20 mbar for 5 s, and detection at 280
nm.
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Figure 47: 5-hydroxy-D,L-tryptophan (0.22 mg/ml) binding by unmodified BSA (A)

and 1 week modified BSA (B). The serum protein concentration was held at 35 μM.
ACE conditions: 15 kV, 25°C, injection at 20 mbar for 5 s, and detection at 280 nm.
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Figure 48: 5-hydroxy-D,L-tryptophan (0.22 mg/ml) binding by 2 week modified

BSA (A) and 3 week modified BSA (B). The serum protein concentration was held
at 35 μM. ACE conditions: 15 kV, 25°C, injection at 20 mbar for 5 s, and detection at
280 nm.
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Figure 49: Effect of glycation extent on BSA selectivity of

D,L-tryptophan. The serum protein concentration was held at 35 μM. ACE
conditions: 15 kV, 25°C, injection at 20 mbar for 5 s, and detection at 280 nm.
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Figure 50: Effect of glycation extent on BSA selectivity of 5-fluoro-D,L-tryptophan.

The serum protein concentration was held at 35 μM. ACE conditions: 15 kV, 25°C,
injection at 20 mbar for 5 s, and detection at 280 nm.
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Figure 51: Effect of glycation extent on BSA selectivity of 5-hydroxy-D,L-

tryptophan. The serum protein concentration was held at 35 μM. ACE conditions: 15
kV, 25°C, injection at 20 mbar for 5 s, and detection at 280 nm.
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The results indicate that albumin functional properties are impacted by glycation-

induced modifications of its structure. Some of the main glycation sites are located
in the vicinity of known drug binding sites (Wa et al., 2007). The extent of glycation
depends upon the time of incubation and in periods of less than 10 days, early stage
glycation products that arise from Schiff base reactions occur in the central body of
the protein (Cohen, 2003; Schmitt et al., 2005; Coussons et al., 1997). The latter
stages of glycation occur on the C- and N- terminal regions causing the body of the
protein to be effected by glycation first. The L-tryptophan binding site (site II) is
located in a hydrophobic cleft between two predominant helical structures in the body
of the protein (Peyrin et al., 1999; Kragh-Hansen et al., 2001). Any changes in the
helical arrangement of BSA induced by the glycation process will alter its binding,
which correlates to shifts in enantioselection of tryptophan.
Based upon this, a postulated explanation for the observed fluctuations in
enantioselection is that the glycation induced by incubating BSA in D-glucose for two
weeks, reduced the helical stability of BSA and led to a decreased binding of Ltryptophan. An earlier study showed that low levels of glucose partially denatured
the protein and decreased the degree of L-tryptophan binding (Barzegar et al., 2007)
supporting the results. The effects of this structural change on binding, were not
observed in the case of 5-fluoro-D,L-tryptophan due to its higher binding affinity for
BSA. By allowing the BSA to incubate in D-glucose solution for 3 weeks, binding
affinity of tryptophan recovered, suggesting further glycation enhanced the helical
stability of BSA. Previous studies by equilibrium dialysis have shown stabilization of
the protein’s structure occurs when high concentrations of glucose are present on the
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protein (Bohney & Feldhoff, 1992). Further support of these results, is BSA
incubated in high concentrations of glucose have been reported to exhibit similar
binding properties to unmodified BSA (Bohney & Feldhoff, 1992). The recovery of
binding by BSA observed after 3 weeks of incubation in D-glucose may be attributed
to this stabilization. Further structural studies will need to be carried out to verify
these postulated conclusions.
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Chapter 4
Conclusion and Future Studies
4.1. Summary
In this dissertation a satisfactory capillary electrophoresis method using protein
CSPs for enantiomer separation was developed. In the first section of this dissertation,
the influences of separation voltage, surface regeneration protocols using sodium
hydroxide/water, background electrolyte rinsing time, sample buffer ionic strength,
and protein diffusion were studied. In doing this, the tryptophan-albumin system was
used as a model at a pH, temperature, and ionic strength optimal for BSA binding.
The results indicate that accurate binding measurements are obtained not only by
assuring the conditions of the microenvironment are conducive for protein binding,
but also by optimizing relevant experimental conditions of the capillary
electrophoresis instrument. Also from this study, it was determined that unlike
previously proposed, allowing the liquid to stand still in the capillary prior to
separation, does not adversely effect separation, but can enhance separation. Future
protein diffusion studies aimed at characterizing this relationship should be carried
out to gain a better understanding of the mechanisms involved.
In the last two sections of this work, it was demonstrated that CE can be applied
for studying biochemical processes. It presents itself as both a means for developing
serum albumin based selective analysis techniques and a convenient approach for
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characterizing the molecular interactions of protein with drugs. In its use for studying
the displacement of tryptophan by ibuprofen, it was found that possible preformed
ibuprofen-BSA complexes may have altered binding and thereby introduce error in
binding measurements. Future studies, that incorporate steps for controlling or
normalizing for these contributions, would be of value for calculating accurate
binding constants.
In the last section, it was indicated by differences in the chiral recognition of
non-glycated BSA and BSA glycated at various degrees, that NMR affirmed
structural change on BSA led to alterations in its binding of tryptophan.
Conformational and functional changes of BSA depend upon the amount of glycation.
A better understanding of the differences in binding is possible through more detailed
structural studies.
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APPENDIX

List of Abbreviations
API

Active Pharmaceutical Ingredients

ACE

Affinity Capillary Electrophoresis

CE

Capillary Electrophoresis

NMR

Nuclear Magnetic Resonance

EOF

Electroosmotic Flow

CSPs

Chiral Stationary Phases

HSA

Human Serum Albumin

BSA

Bovine Serum Albumin

AGP

α1-acid glycoprotein

OVM

Ovumocoid

HPLC

High Pressure Liquid Chromatography

BGE

Background Electrolyte

SDS

Sodium dodecyl sulfate

UV

Ultra Violet

NaOH

Sodium hydroxide

pH

- log[H]+

Trp

D,L-Tryptophan
177

List of Abbreviations (Continued)
5-Flo

5-fluoro-D,L-tryptophan

Ibu

Ibuprofen

Au

Absorbance Units

DAD

Diode Array Detector

R2

Square of the correlation coefficient

μan

electrophoretic mobility of solute
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